Advertisement

Indikationsabhängige Durchführung und Bewertung der Elektrokonvulsionstherapie

  • Baghai
  • Rupprecht
  • Möller
  • Adli
  • Bauer
  • Grunze
  • Scharfetter
  • Schäfer
  • Conca
  • Riedel
  • Strassnig
  • Möller
  • Müller
  • Müller-Siecheneder
  • Praschak-Rieder
  • Willeit

Zusammenfassung

Nachdem 1938 die erste elektrokonvulsive Behandlung eines schizophrenen Patienten stattgefunden hatte und zu dieser Zeit keine andere somatische Therapie depressiver Erkrankungen etabliert war, wurden in den 40er Jahren die ersten unter einer Depression leidenden Patienten durch eine Elektrokonvulsionstherapie (EKT) effektiv behandelt [173]. Durch die erstmalige Einf¨¹hrung einer biologischen Therapie depressiver Erkrankungen konnte die Mortalität und die Rate chronifizierter Erkrankungen gesenkt werden [20, 21, 125, 127, 176]. Nach der Etablierung der Antidepressiva im Gefolge der Einführung des Imipramins (1958) ging die Anwendungshäufigkeit der EKT zurück. Weiterhin blieb jedoch die Wirksamkeit der EKT in der Depressionstherapie ein Maßstab zur Beurteilung der Wirksamkeit einer Pharmakotherapie [173].

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

  1. 1.
    The Northwick Park Clinical Research Centre (1984)The Northwick Park ECT trial. Predictors of response to real and simulated ECT. Clinical Research Centre, Division of Psychiatry. Br J Psychiatry 144: 227–237Google Scholar
  2. 2.
    Abrams R (1982) ECT and tricyclic antidepressants in the treatment of endogenous depression. Psychopharmacol Bull 18: 73–75PubMedGoogle Scholar
  3. 3.
    Abrams R (1997) Electroconvulsive Therapy. Oxford University Press, New York, OxfordGoogle Scholar
  4. 4.
    Abrams R (1997) The mortality rate with ECT. Convuls Ther 13: 125–127PubMedGoogle Scholar
  5. 5.
    Abrams R (2000) Use of ECT in Italy. Am J Psychiatry 157: 840PubMedGoogle Scholar
  6. 6.
    Abrams R (2002) Electroconvulsive Therapy. Oxford University Press, Oxford, New YorkGoogle Scholar
  7. 7.
    Abrams R, Fink M, Feldstein S (1973) Prediction of clinical response to ECT. Br J Psychiatry 122: 457–460PubMedGoogle Scholar
  8. 8.
    Abrams R, Swartz C M, Vedak C (1991) Antidepressant effects of high-dose right unilateral electroconvulsive therapy. Arch Gen Psychiatry 48: 746–748PubMedGoogle Scholar
  9. 9.
    Abrams R, Taylor M A (1974) Unipolar and bipolar depressive illness. Phenomenology and response to electroconvulsive therapy. Arch Gen Psychiatry 30: 320–321Google Scholar
  10. 10.
    Abrams R, Taylor M A (1976) Catatonia. A prospective clinical study. Arch Gen Psychiatry 33: 579–581Google Scholar
  11. 11.
    Agelink M W, Andrich J, PostertT, Wurzinger U, ZeitT, Klotz P, Przuntek H (2001) Relation between electroconvulsive therapy, cognitive side effects, neuron specific enolase, and protein S-100.1 Neurol Neurosurg Psychiatry 71: 394–396Google Scholar
  12. 12.
    Allman P, Hawton K (1987) ECT for Poststroke Depression: Beta Blockade to Modify Rise in Blood Pressure. ConvulsTher 3: 218–221Google Scholar
  13. 13.
    American Psychiatric Association (1994) Diagnostic and Statistical Manual of Mental Disorders (DSM-IV). Washington DC, USAGoogle Scholar
  14. 14.
    Andrade C, Gangadhar B N, Channabasavanna S M (1987) Mania associated with electroconvulsive therapy. J Clin Psychiatry 48: 303–304PubMedGoogle Scholar
  15. 15.
    Andrade C, Gangadhar B N, Swaminath G, Channabasavanna S M (1988) Predicting the Outcome of Endogenous Depression Following Electroconvulsive Therapy. ConvulsTher 4: 169–174Google Scholar
  16. 16.
    Angst J, Angst K, Baruffol I, Meinherz-Surbeck R (1992) ECT-Induced and Drug-Induced Hypomania. ConvulsTher 8: 179–185Google Scholar
  17. 17.
    Aronson T A, Shukla S, Hoff A, Cook B (1988) Proposed delusional depression subtypes: preliminary evidence from a retrospective study of phenomenology and treatment course. J Affect Disord 14: 69–74PubMedGoogle Scholar
  18. 18.
    Auquier P, Hodgkinson M, Thirion X, Tramoni AV (1994) [Attitude of psychiatrists to electrotherapy]. Encephale 20: 713–717Google Scholar
  19. 19.
    Avery D, Lubrano A (1979) Depression treated with imipramine and ECT: the DeCarolis study reconsidered. Am J Psychiatry 136: 559–562PubMedGoogle Scholar
  20. 20.
    Avery D, Winokur G (1976) Mortality in depressed patients treated with electroconvulsive therapy and antidepressants. Arch Gen Psychiatry 33: 1029–1037PubMedGoogle Scholar
  21. 21.
    Babigian H M, Guttmacher L B (1984) Epidemiologic considerations in electroconvulsive therapy. Arch Gen Psychiatry 41: 246–253PubMedGoogle Scholar
  22. 22.
    Beale M D, Kellner C H, Pritchett J T, Burns C M (1995) ECT for OCD. J Clin Psychiatry 56: 81–82Google Scholar
  23. 23.
    Beliles K, Stoudemire A (1998) Psychopharmacologic treatment of depression in the medically ill. Psychosomatics 39: S2–19PubMedGoogle Scholar
  24. 24.
    Benadhira R, Teles A (2001) [Current status of electroconvulsive therapy in adult psychiatric care in France]. Encephale 27: 129–136Google Scholar
  25. 25.
    Bernardo M, Arrufat F, Pintor L, Catarineu S, Buisan E, Ballus C (1996) [Patterns of the use of electroconvulsive therapy in Barcelona]. Med Clin (Barc) 106: 201–204Google Scholar
  26. 26.
    Bernardo M, Arrufat F, Pintor L, Catarineu S, Buisan E, Ballus C (1996) [Patterns of the use of electroconvulsive therapy in Barcelona]. Med Clin (Barc) 106: 201–204Google Scholar
  27. 27.
    Bernardo M, Navarro V, Salva J, Arrufat F J, Baeza I (2000) Seizure activity and safety in combined treatment with venlafaxine and ECT: a pilot study. J ECT 16: 38–42Google Scholar
  28. 28.
    Bibb R C, Guze S B (1972) Hysteria (Briquet’s syndrome) in a psychiatric hospital: the significance of secondary depression. Am J Psychiatry 129: 224–228PubMedGoogle Scholar
  29. 29.
    Black D W, Bell S, Hulbert J, Nasrallah A (1988) The importance of Axis II in patients with major depression. A controlled study. J Affect Disord 14: 115–122Google Scholar
  30. 30.
    Black D W, Winokur G, Nasrallah A (1986) ECT in Unipolar and Bipolar Disorders: A Naturalistic Evaluation of 460 Patients. Convuls Ther 2: 231–237PubMedGoogle Scholar
  31. 31.
    Black D W, Winokur G, Nasrallah A (1989) Illness Duration and Acute Response in Major Depression. ConvulsTher 5: 338–343Google Scholar
  32. 32.
    Black D W, Winokur G, Nasrallah A (1993) A Multivariate Analysis of the Experience of 423 Depressed Inpatients Treated with ElectroconvulsiveTherapy. ConvulsTher 9: 112–120Google Scholar
  33. 33.
    Brandon S, Cowley P, McDonald C, Neville P, Palmer R, Wellstood-Eason S (1984) Electroconvulsive therapy: results in depressive illness from the Leicestershire trial. Br Med J (Clin Res Ed) 288: 22–25Google Scholar
  34. 34.
    Breakey W R, Kala A K (1977) Typhoid catatonia responsive to ECT. Br Med J 2: 357–359PubMedGoogle Scholar
  35. 35.
    Brodaty H, Berle D, Hickie I, Mason C (2001) „Side effects“ of ECT are mainly depressive phenomena and are independent of age. J Affect Disord 66: 237–245Google Scholar
  36. 36.
    Buchan H, Johnstone E, McPherson K, Palmer R L, Crow T J, Brandon S (1992) Who benefits from electroconvulsive therapy? Combined results of the Leicester and Northwick Park trials. Br J Psychiatry 160: 355–359PubMedGoogle Scholar
  37. 37.
    Bush G, Fink M, Petrides G, Dowling F, Francis A (1996) Catatonia. II. Treatment with lorazepam and electroconvulsive therapy. Acta Psychiatr Scand 93: 137–143Google Scholar
  38. 38.
    Calev A, Gaudino E A, Squires N K, Zervas I M, Fink M (1995) ECT and non-memory cognition: a review. Br J Clin Psychol 34 (Pt 4): 505–515PubMedGoogle Scholar
  39. 39.
    Calev A, Nigal D, Shapira B, Tubi N, Chazan S, Ben Yehuda Y, Kugelmass S, Lerer B (1991) Early and long-term effects of electroconvulsive therapy and depression on memory and other cognitive functions. J Nery Ment Dis 179: 526–533Google Scholar
  40. 40.
    Carney M W, Rogan P A, Sebastian J, Sheffield B (1976) A controlled comparative trial of unilateral and bilateral sinusoidal and pulse ECT in endogenous depression. PDM 7(9–12)8: 77–79Google Scholar
  41. 41.
    Casey D A, Davis M H (1994) Obsessive-compulsive disorder responsive to electroconvulsive therapy in an elderly woman. South Med J 87: 862–864PubMedGoogle Scholar
  42. 42.
    Chan C H, Janicak P G, Davis J M, Altman E, Andriukaitis S, Hedeker D (1987) Response of psychotic and nonpsychotic depressed patients to tricyclic antidepressants. J Clin Psychiatry 48: 197–200PubMedGoogle Scholar
  43. 43.
    Cohen D, Taieb O, Flament M, Benoit N, Chevret S, Corcos M, Fossati P, Jeammet P, Allilaire J F, Basquin M (2000) Absence of cognitive impairment at long-term follow-up in adolescents treated with ECT for severe mood disorder. Am J Psychiatry 157: 460–462PubMedGoogle Scholar
  44. 44.
    Coryell W, Pfohl B, Zimmerman M (1985) Outcome Following ElectroconvulsiveTherapy: A Comparison of Primary and Secondary Depression. Convuls Ther 1: 10–14Google Scholar
  45. 45.
    Coryell W, Zimmerman M (1984) Outcome following ECT for primary unipolar depression: a test of newly proposed response predictors. Am J Psychiatry 141: 862–867PubMedGoogle Scholar
  46. 46.
    Davidson J, McLeod M, Law-Yone B, Linnoila M (1978) A comparison of electroconvulsive therapy and combined phenelzine-amitriptyline in refractory depression. Arch Gen Psychiatry 35: 639–642PubMedGoogle Scholar
  47. 47.
    DeBattista C, Mueller K (2001) Is electroconvulsive therapy effective for the depressed patient with comorbid borderline personality disorder? J ECT 17: 91–98Google Scholar
  48. 48.
    Delva N J, Brunet D, Hawken E R, Kesteven R M, Lawson J S, Lywood D W, Rodenburg M, Waldron J J (2000) Electrical dose and seizure threshold: relations to clinical outcome and cognitive effects in bifrontal, bitemporal, and right unilateral ECT. J ECT 16: 361–369Google Scholar
  49. 49.
    DeQuardo J R, Tandon R (1988) Concurrent lithium therapy prevents ECT-induced switch to mania. J Clin Psychiatry 49: 167–168PubMedGoogle Scholar
  50. 50.
    Devanand D P, Decina P, Sackeim H A, Prudic J (1988) Status epilepticus following ECT in a patient receiving theophylline. J Clin Psychopharmacol 8: 153PubMedGoogle Scholar
  51. 51.
    Devanand D P, Dwork A J, Hutchinson E R, Bolwig T G, Sackeim H A (1994) Does ECT alter brain structure? Am J Psychiatry 151: 957–970PubMedGoogle Scholar
  52. 52.
    Devanand D P, Fitzsimons L, Prudic J, Sackeim H A (1995) Subjective side effects during electroconvulsive therapy. Convuls Ther 11: 232–240PubMedGoogle Scholar
  53. 53.
    Devanand D P, Sackeim H A, Decina P, Prudic J (1988) The development of mania and organic euphoria during ECT. J Clin Psychiatry 49: 69–71PubMedGoogle Scholar
  54. 54.
    Devanand D P, Verma A K, Tirumalasetti F, Sackeim H A (1991) Absence of cognitive impairment after more than 100 lifetime ECT treatments. Am J Psychiatry 148: 929–932PubMedGoogle Scholar
  55. 55.
    DietzfelbingerT, Möller H J, Steinmeier E M, Fimmers R (1990) Elektrokrampftherapie als Ultima ratio bei Antidepressiva-Nonrespondern. In: Möller H J (ed)Therapieresistenz unter Antidepressiva-Behandlung. Springer, Berlin Heidelberg New York, 176–185Google Scholar
  56. 56.
    Dinan T G, Barry S (1989) A comparison of electroconvulsive therapy with a combined lithium and tricyclic combination among depressed tricyclic nonresponders. Acta Psychiatr Scand 80: 97–100PubMedGoogle Scholar
  57. 57.
    Dunn C G, Quinlan D (1978) Indicators of E.C.T. response and non-response in the treatment of depression. J Clin Psychiatry 39: 620–622PubMedGoogle Scholar
  58. 58.
    el Ganzouri A R, lvankovich A D, Braverman B, McCarthy R (1985) Monoamine oxidase inhibitors: should they be discontinued preoperatively? Anesth Analg 64: 592–596PubMedGoogle Scholar
  59. 59.
    Flint A J, Rifat S L (1998)The treatment of psychotic depression in later life: a comparison of pharmacotherapy and ECT. Int J Geriatr Psychiatry 13: 23–28Google Scholar
  60. 60.
    Folkerts H W, Michael N, Tolle R, Schonauer K, Mucke S, Schulze-Monking H (1997) Electroconvulsive therapy vs. paroxetine in treatment-resistant depression — a randomized study. Acta Psychiatr Scand 96: 334–342PubMedGoogle Scholar
  61. 61.
    Folstein M, Folstein S, McHugh P R (1973) Clinical predictors of improvement after electroconvulsive therapy of patients with schizophrenia, neurotic reactions, and affective disorders. Biol Psychiatry 7: 147–152PubMedGoogle Scholar
  62. 62.
    Franco-Bronson K (1996)The management of treatment-resistant depression in the medically ill. Psychiatr Clin North Am 19: 329–350Google Scholar
  63. 63.
    Freeman C P (1978) The therapeutic efficacy of electroconvulsive therapy (ECT). A double blind controlled trial of ECT and simulated ECT. Scott Med J 23: 71–75PubMedGoogle Scholar
  64. 64.
    Freeman C P, Basson J V, Crighton A (1978) Double-blind controlled trail of electroconvulsive therapy (E.C.T.) and simulated E.C.T. in depressive illness. Lancet 1: 738–740Google Scholar
  65. 65.
    Freese K J (1985) Can Patients Safely Undergo Electroconvulsive Therapy While Receiving Monoamine Oxidase Inhibitors? Convuls Ther 1: 190–194PubMedGoogle Scholar
  66. 66.
    Frey R, Schreinzer D, Heiden A, Kasper S (2001) [Use of electroconvulsive therapy in psychiatry]. Nervenarzt 72: 661–676Google Scholar
  67. 67.
    Gangadhar B N, Kapur R L, Kalyanasundaram S (1982) Comparison of electroconvulsive therapy with imipramine in endogenous depression: a double blind study. Br J Psychiatry 141: 367–371PubMedGoogle Scholar
  68. 68.
    Genz A, Krause P, Koch R D, Knorr W (1985) [Side effects of bilateral electroconvulsive therapy-comparative clinico-computer tomographic study]. Psychiatr Neurol Med Psychol (Leipz) 37: 197–204Google Scholar
  69. 69.
    Geretsegger C, Rochowanski E (1987) Electroconvulsive Therapy in Acute Life-Threatening Catatonia with Associated Cardiac and Respiratory Decompensation. Convuls Ther 3: 291295Google Scholar
  70. 70.
    Ghaziuddin N, Laughrin D, Giordani B (2000) Cognitive side effects of electroconvulsive therapy in adolescents. J Child Adolesc Psychopharmacol 10: 269–276PubMedGoogle Scholar
  71. 71.
    Glen T, Scott A I (1999) Rates of electroconvulsive therapy use in Edinburgh (1992–1997). J Affect Disord 54: 81–85PubMedGoogle Scholar
  72. 72.
    Glen T, Scott A I (2000) Variation in rates of electroconvulsive therapy use among consultant teams in Edinburgh (1993–1996). J Affect Disord 58: 75–78PubMedGoogle Scholar
  73. 73.
    Gonzalez-Pinto A, Gutierrez M, Gonzalez N, Elizagarate E, Perez De Heredia J L, Mico J A (2002) Efficacy and Safety of Venlafaxine-ECT Combination in Treatment-Resistant Depression. J Neuropsychiatry Clin Neurosci 14: 206–209PubMedGoogle Scholar
  74. 74.
    Greenblatt M, Grosser G H, Wechsler H A (1964) Differential response of hospitalized depressed patients in somatic therapy. Am J Psychiatry 935–943Google Scholar
  75. 75.
    Gregory S, Shawcross C R, Gill D (1985)The Nottingham ECT Study. A double-blind comparison of bilateral, unilateral and simulated ECT in depressive illness. Br J Psychiatry 146: 520–524Google Scholar
  76. 76.
    Grogan R, Wagner D R, Sullivan T, Labar D (1995) Generalized nonconvulsive status epilepticus after electroconvulsive therapy. Convuls Ther 11: 51–56PubMedGoogle Scholar
  77. 77.
    Hafeiz H B (1987) Psychiatric manifestations of enteric fever. Acta Psychiatr Scand 75: 6973Google Scholar
  78. 78.
    Heshe J, Roeder E (1976) Electroconvulsive therapy in Denmark. Br J Psychiatry 128: 241245Google Scholar
  79. 79.
    Hickie I, Mason C, Parker G, Brodaty H (1996) Prediction of ECT response: validation of a refined sign-based ( CORE) system for defining melancholia. Br J Psychiatry 169: 68–74Google Scholar
  80. 80.
    Hickie I, Parsonage B, Parker G (1990) Prediction of response to electroconvulsive therapy. Preliminary validation of a sign-based typology of depression. Br J Psychiatry 157: 65–71Google Scholar
  81. 81a.
    Hill G E, Wong K C, Hodges M R (1977) Lithium carbonate and neuromuscular blocking agents. Anesthesiology 46: 122–126PubMedGoogle Scholar
  82. 81.
    b. Hofmann P, Wieselmann G, Herzog G, Zapotoczky H G (1993) Elektrokonvulsionstherapie (EKT) in Österreich. Eine Umfrage. Neuropsychiatrie 7: 204–206Google Scholar
  83. 82.
    Janicak P G, Davis J M, Gibbons R D, Ericksen S, Chang S, Gallagher P (1985) Efficacy of ECT: a metaanalysis. Am J Psychiatry 142: 297–302PubMedGoogle Scholar
  84. 83.
    Johnstone E C, Deakin J F, Lawler P, Frith C D, Stevens M, McPherson K, Crow J (1980)The Northwick Park electroconvulsive therapy trial. Lancet 2: 1317–1320Google Scholar
  85. 84.
    Kindler S, Shapira B, Hadjez J, Abramowitz M, Brom D, Lerer B (1991) Factors Influencing Response to Bilateral Electroconvulsive Therapy in Major Depression. Convuls Ther 7: 245–254PubMedGoogle Scholar
  86. 85.
    Kornstein S G, Schneider R K (2001) Clinical features of treatment-resistant depression. J Clin Psychiatry 62 [Suppl] 16: 18–25Google Scholar
  87. 86.
    Kramer B A (1999) Use of ECT in California, revisited: 1984–1994. J ECT 15: 245–251Google Scholar
  88. 87.
    Krause P, Genz A, Knorr W (1988) [Prospective study of the late sequelae of electroconvulsive treatment]. Psychiatr Neurol Med Psychol (Leipz) 40: 532–536Google Scholar
  89. 88.
    Kroessler D (1985) Relative Efficacy Rates for Therapies of Delusional Depression. Convuls Ther 1: 173–182PubMedGoogle Scholar
  90. 89.
    Krystal A D, Coffey C E (1997) Neuropsychiatric considerations in the use of electroconvulsive therapy. J Neuropsychiatry Clin Neurosci 9: 283–292PubMedGoogle Scholar
  91. 90.
    Kukopulos A, Reginaldi D, Tondo L, Bernabei A, Caliari B (1977) Spontaneous length of depression and response to ECT. Psychol Med 7: 625–629PubMedGoogle Scholar
  92. 91.
    Lambourn J, Gill D (1978) A controlled comparison of simulated and real ECT. Br J Psychiatry 133: 514–519PubMedGoogle Scholar
  93. 92.
    Latey R H, FahyT J (1988) Some influences on regional variation in frequency of prescription of electroconvulsive therapy. Br J Psychiatry 152: 196–200Google Scholar
  94. 93.
    Lauritzen L, Odgaard K, Clemmesen L, Lunde M, Ohrstrom J, Black C, Bech P (1996) Relapse prevention by means of paroxetine in ECT-treated patients with major depression: a comparison with imipramine and placebo in medium-term continuation therapy. Acta Psychiatr Scand 94: 241–251PubMedGoogle Scholar
  95. 94.
    Lemstra A, Leentjens A F, van den Broek W W (1996) [Temporary results only in electroconvulsive therapy in therapy-resistant depression; retrospective study]. Ned Tijdschr Geneeskd 140: 260–264Google Scholar
  96. 95.
    Lisanby S H, Maddox J H, Prudic J, Devanand D P, Sackeim H A (2000) The effects of electroconvulsive therapy on memory of autobiographical and public events. Arch Gen Psychiatry 57: 581–590PubMedGoogle Scholar
  97. 96.
    Lykouras E, Malliaras D, Christodoulou G N, Moussas G, Christodoulou D,Tzonou A (1986) Delusional depression: phenomenology and response to treatment. Psychopathology 19: 157–164Google Scholar
  98. 97.
    Lykouras E, Malliaras D, Christodoulou G N, PapakostasY, Voulgari A, Tzonou A, Stefanis C (1986) Delusional depression: phenomenology and response to treatment. A prospective study. Acta Psychiatr Scand 73: 324–329Google Scholar
  99. 98.
    Magni G, Fisman M, Helmes E (1988) Clinical correlates of ECT-resistant depression in the elderly. J Clin Psychiatry 49: 405–407PubMedGoogle Scholar
  100. 99.
    Maletzky B, McFarland B, Burt A (1994) Refractory obsessive compulsive disorder and ECT. ConvulsTher 10: 34–42Google Scholar
  101. 100.
    Mann S C, Caroff S N, Bleier H R, Antelo R E, Un H (1990) ElectroconvulsiveTherapy of the Lethal Catatonia Syndrome. ConvulsTher 6: 239–247Google Scholar
  102. 101.
    Mann S C, Caroff S N, Bleier H R, Welz W K, Kling M A, Hayashida M (1986) Lethal catatonia. Am J Psychiatry 143: 1374–1381PubMedGoogle Scholar
  103. 102.
    Markowitz J S, Kellner C H, DeVane C L, Beale M D, Folk J, Burns C, Liston H L (2001) Intranasal sumatriptan in post-ECT headache: results of an open-label trial. J ECT 17: 280283Google Scholar
  104. 103.
    McCall WV (2001) Electroconvulsive therapy in the era of modern psychopharmacology. Int J Neuropsychopharmacol 4: 315–324PubMedGoogle Scholar
  105. 104.
    McCall WV, Reboussin D M, Weiner R D, Sackeim H A (2000) Titrated moderately supra-threshold vs fixed high-dose right unilateral electroconvulsive therapy: acute antidepressant and cognitive effects. Arch Gen Psychiatry 57: 438–444PubMedGoogle Scholar
  106. 105.
    McDonald I M, Perkins M, Marjerrison G, Podilsky M (1966) A controlled comparison of amitriptyline and electroconvulsive therapy in the treatment of depression. Am J Psychiatry 122: 1427–1431PubMedGoogle Scholar
  107. 106.
    Mellman L A, Gorman J M (1984) Successful treatment of obsessive-compulsive disorder with ECT. Am J Psychiatry 141: 596–597PubMedGoogle Scholar
  108. 107.
    Mollenberg 0 (1997) [Electroconvulsive therapy-anesthesiological procedures]. Anasthesiol Intensivmed Notfallmed Schmerzther 32: 593–603Google Scholar
  109. 108.
    Möller H J (1997) Therapieresistenz unter Antidepressiva: Definition, Epidemiologie and Risikofaktoren. In: Bauer M, Berghöfer A (eds) Therapieresistente Depressionen. Springer, Berlin Heidelberg, 3–15Google Scholar
  110. 109.
    Möller H J, Laux G, Kapfhammer H P (1999) Psychiatrie and Psychotherapie. Srpinger, Berlin, HeidelbergGoogle Scholar
  111. 110.
    Muller U, Klimke A, Janner M, Gaebel W (1998) [Electroconvulsive therapy in psychiatric clinics in Germany in 19951. Nervenarzt 69: 15–26Google Scholar
  112. 111.
    Mulsant B H, Haskett R F, Prudic J, Thase M E, Malone K M, Mann J J, Pettinati H M, Sackeim H A (1997) Low use of neuroleptic drugs in the treatment of psychotic major depression. Am J Psychiatry 154: 559–561PubMedGoogle Scholar
  113. 112.
    Murray G B, Shea V, Conn D K (1986) Electroconvulsive therapy for poststroke depression. J Clin Psychiatry 47: 258–260PubMedGoogle Scholar
  114. 113.
    Nelson J C, Price L H, Jatlow P I (1986) Neuroleptic dose and desipramine concentrations during combined treatment of unipolar delusional depression. Am J Psychiatry 143: 1151–1154PubMedGoogle Scholar
  115. 114.
    Nelson J P, Benjamin L (1989) Efficacy and Safety of Combined ECT and Tricyclic Antidepressant Drugs in the Treatment of Depressed Geriatric Patients. Convuls Ther 5: 321–329PubMedGoogle Scholar
  116. 115.
    Ng C, Schweitzer I, Alexopoulos P, Celi E, Wong L, Tuckwell V, Sergejew A, Tiller J (2000) Efficacy and cognitive effects of right unilateral electroconvulsive therapy. J ECT 16: 370–379Google Scholar
  117. 116.
    Nobler M S, Sackeim H A, Moeller J R, Prudic J, Petkova E, Waternaux C (1997) Quantifying the speed of symptomatic improvement with electroconvulsive therapy: comparison of alternative statistical methods. ConvulsTher 13: 208–221Google Scholar
  118. 117.
    O’Toole J K, Dyck G (1977) Report of psychogenic fever in catatonia responding to electroconvulsive therapy. Dis New Syst 38: 852–853Google Scholar
  119. 118.
    Pande A C, Grunhaus L J, Haskett R F, Greden J F (1990) Electroconvulsive therapy in delusional and non-delusional depressive disorder. J Affect Disord 19: 215–219PubMedGoogle Scholar
  120. 119.
    Parker G, Roy K, Hadzi-Pavlovic D, Pedic F (1992) Psychotic (delusional) depression: a metaanalysis of physical treatments. J Affect Disord 24: 17–24PubMedGoogle Scholar
  121. 120.
    Perris C, d’Elia G (1966) A study of bipolar (manic-depressive) and unipolar recurrent depressive psychoses. IX. therapy and prognosis. Acta Psychiatr Scand [Suppl] 194: 153–171Google Scholar
  122. 121.
    Perry P J, Morgan D E, Smith R E, Tsuang M T (1982) Treatment of unipolar depression accompanied by delusions. ECT versus tricyclic antidepressant-antipsychotic combinations. J Affect Disord 4: 195–200Google Scholar
  123. 122.
    Peters S G, Wochos D N, Peterson G C (1984) Status epilepticus as a complication of concurrent electroconvulsive and theophylline therapy. Mayo Clin Proc 59: 568–570PubMedGoogle Scholar
  124. 123.
    Pettinati H M, Bonner K M (1984) Cognitive functioning in depressed geriatric patients with a history of ECT. Am J Psychiatry 141: 49–52PubMedGoogle Scholar
  125. 124.
    Philbrick K L, RummansT A (1994) Malignant catatonia. J Neuropsychiatry Clin Neurosci 6: 1–13Google Scholar
  126. 125.
    Philibert RA, Richards L, Lynch C F, Winokur G (1995) Effect of ECT on mortality and clinical outcome in geriatric unipolar depression. J Clin Psychiatry 56: 390–394PubMedGoogle Scholar
  127. 126.
    Pluijms E M, BirkenhagerT K, Huijbrechts I P, Moleman P (2002) Influence of resistance to antidepressant pharmacotherapy on short-term response to electroconvulsive therapy. J Affect Disord 69: 93–99PubMedGoogle Scholar
  128. 127.
    Post F (1972)The management and nature of depressive illnesses in late life: a follow-through study. Br J Psychiatry 121: 393–404Google Scholar
  129. 128.
    Prudic J, Devanand D P, Sackeim H A, Decina P, Kerr B (1989) Relative response of endogenous and non-endogenous symptoms to electroconvulsive therapy. J Affect Disord 16: 59–64PubMedGoogle Scholar
  130. 129.
    Prudic J, Haskett R F, Mulsant B, Malone K M, Pettinati H M, Stephens S, Greenberg R, Rifas S L, Sackeim H A (1996) Resistance to antidepressant medications and short-term clinical response to ECT. Am J Psychiatry 153: 985–992PubMedGoogle Scholar
  131. 130.
    Prudic J, Sackeim H A, Devanand D P (1990) Medication resistance and clinical response to electroconvulsive therapy. Psychiatry Res 31: 287–296PubMedGoogle Scholar
  132. 131.
    Quitkin F M (1985) The importance of dosage in prescribing antidepressants. Br J Psychiatry 147: 593–597PubMedGoogle Scholar
  133. 132.
    Quitkin F M, McGrath P J, Stewart J W, Taylor B P, Klein D F (1996) Can the effects of antidepressants be observed in the first two weeks of treatment? Neuropsychopharmacology 15: 390–394PubMedGoogle Scholar
  134. 133.
    Quitkin F M, Rabkin J G, Ross D, McGrath P J (1984) Duration of antidepressant drug treatment. What is an adequate trial? Arch Gen Psychiatry 41: 238–245PubMedGoogle Scholar
  135. 134.
    Rabheru K, Persad E (1997) A review of continuation and maintenance electroconvulsive therapy. Can J Psychiatry 42: 476–484PubMedGoogle Scholar
  136. 135.
    Rao K M, Gangadhar B N, Janakiramaiah N (1993) Nonconvulsive Status Epilepticus after the Ninth Electroconvulsive Therapy. Convuls Ther 9: 128–129PubMedGoogle Scholar
  137. 136.
    Rasmussen K G, Rummans T A, Richardson J W (2002) Electroconvulsive therapy in the medically ill. Psychiatr Clin North Am 25: 177–193PubMedGoogle Scholar
  138. 137.
    Rasmussen K G, Zorumski C F (1993) Electroconvulsive therapy in patients taking theophylline. J Clin Psychiatry 54: 427–431PubMedGoogle Scholar
  139. 138.
    Reimherr F W, Hodges M R, Hill G E, Wong K C (1977) Prolongation of muscle relaxant effects by lithium carbonate. Am J Psychiatry 134: 205–206PubMedGoogle Scholar
  140. 139.
    Rifkin A (1988) ECT versus tricyclic antidepressants in depression: a review of the evidence. J Clin Psychiatry 49: 3–7PubMedGoogle Scholar
  141. 140.
    Rohland B M, Carroll BT, Jacoby R G (1993) ECT in the treatment of the catatonic syndrome. J Affect Disord 29: 255–261PubMedGoogle Scholar
  142. 141.
    Roose S P, Glassman A H, Walsh BT, Woodring S, Vital-Herne J (1983) Depression, delusions, and suicide. Am J Psychiatry 140: 1159–1162PubMedGoogle Scholar
  143. 142.
    Rothschild A J (1996) Management of psychotic, treatment-resistant depression. Psychiatr Clin North Am 19: 237–252PubMedGoogle Scholar
  144. 143.
    Rothschild AL Samson J A, Bessette M P, Carter-Campbell J T (1993) Efficacy of the combination of fluoxetine and perphenazine in the treatment of psychotic depression. J Clin Psychiatry 54: 338–342PubMedGoogle Scholar
  145. 144.
    Rubin E H, Kinscherf D A, Figiel G S, Zorumski C F (1993) The nature and time course of cognitive side effects during electroconvulsive therapy in the elderly. J Geriatr Psychiatry N eu ro l 6: 78–83Google Scholar
  146. 145.
    Sackeim H A (2001) The definition and meaning of treatment-resistant depression. J Clin Psychiatry 62 [Suppl] 16: 10–17Google Scholar
  147. 146.
    Sackeim H A, Decina P, Kanzler M, Kerr B, Malitz S (1987) Effects of electrode placement on the efficacy of titrated, low-dose ECT. Am J Psychiatry 144: 1449–1455PubMedGoogle Scholar
  148. 147.
    Sackeim H A, Prudic J, Devanand D P, Decina P, Kerr B, Malitz S (1990) The impact of medication resistance and continuation pharmacotherapy on relapse following response to electroconvulsive therapy in major depression. J Clin Psychopharmacol 10: 96–104PubMedGoogle Scholar
  149. 148.
    Sackeim H A, Prudic J, Devanand D P, Kiersky J E, Fitzsimons L, Moody B J, McElhiney M C, Coleman E A, Settembrino J M (1993) Effects of stimulus intensity and electrode placement on the efficacy and cognitive effects of electroconvulsive therapy. N Engl J Med 328: 839–846PubMedGoogle Scholar
  150. 149.
    Sackeim H A, Prudic J, Devanand D P, Nobler M S, Lisanby S H, Peyser S, Fitzsimons L, Moody B J, Clark J (2000) A prospective, randomized, double-blind comparison of bilateral and right unilateral electroconvulsive therapy at different stimulus intensities. Arch Gen Psychiatry 57: 425–434PubMedGoogle Scholar
  151. 150.
    Sackeim H A, Ross F R, Hopkins N, Calev L, Devanand D P (1987) Subjective Side Effects Acutely Following ECT: Associations with Treatment Modality and Clinical Response. Convuls Ther 3: 100–110Google Scholar
  152. 151.
    Sackeim H A, Rush A J (1995) Melancholia and response to ECT. Am J Psychiatry 152: 12421243Google Scholar
  153. 152.
    Sareen J, Enns M W, Guertin J E (2000) The impact of clinically diagnosed personality disorders on acute and one-year outcomes of electroconvulsive therapy. J ECT 16: 43–51Google Scholar
  154. 153.
    Sauer H, Lauter H (1987) [Electroconvulsive therapy. Il. Indications, contraindications and therapeutic technics of electroconvulsive therapy]. Nervenarzt 58: 210–218Google Scholar
  155. 154.
    Scott A I, Riddle W (1989) Status epilepticus after electroconvulsive therapy. Br J Psychiatry 155: 119–121PubMedGoogle Scholar
  156. 155.
    Scott A I, Rodger C R, Stocks R H, Shering A P (1992) Is old-fashioned electroconvulsive therapy more efficacious? A randomised comparative study of bilateral brief-pulse and bilateral sine-wave treatments. Br J Psychiatry 160: 360–364PubMedGoogle Scholar
  157. 156.
    Shiwach R S, Reid W H, Carmody T J (2001) An analysis of reported deaths following electroconvulsive therapy in Texas, 1993–1998. Psychiatr Sery 52: 1095–1097Google Scholar
  158. 157.
    Sobin C, Prudic J, Devanand D P, Nobler M S, Sackeim H A (1996) Who responds to electroconvulsive therapy? A comparison of effective and ineffective forms of treatment. Br J Psychiatry 169: 322–328PubMedGoogle Scholar
  159. 158.
    Solomon R L, Rich C L, Darko D F (1990) Antidepressant treatment and the occurrence of mania in bipolar patients admitted for depression. J Affect Disord 18: 253–257PubMedGoogle Scholar
  160. 159.
    Sonawal la S B, Fava M (2001) Severe depression: is there a best approach? CNS Drugs 15: 765–776Google Scholar
  161. 160.
    Soyka M, Niederecker M, Meyendorf R (1991) [Successful treatment of a therapy-refractory compulsive syndrome by electroconvulsive therapy]. Nervenarzt 62: 448–450Google Scholar
  162. 161.
    Spiker D G, Stein J, Rich C L (1985) Delusional Depression and Electroconvulsive Therapy: One Year Later. ConvulsTher 1: 167–172Google Scholar
  163. 162.
    Spiker D G, Weis, J C, Dealy R S, Griffin S1, Hanin I, Neil J F, Perel J M, Rossi A J, Soloff P H (1985)The pharmacological treatment of delusional depression. Am) Psychiatry 142: 430–436Google Scholar
  164. 163.
    Squire L R, Zouzounis J A (1986) ECT and memory: brief pulse versus sine wave. Am J Psychiatry 143: 596–601PubMedGoogle Scholar
  165. 164.
    Stek M L, Beekman AT, Verwey B (1997) [Electroconvulsive therapy in late life depression: a review]. Tijdschr Gerontol Geriatr 28: 106–112Google Scholar
  166. 165.
    Stromgren L S (1973) Unilateral versus bilateral electroconvulsive therapy. Investigations into the therapeutic effect in endogenous depression. Acta Psychiatr Scand [Suppl] 240: 8–65Google Scholar
  167. 166.
    Stromgren L S (1991) Electroconvulsive therapy in the Nordic countries, 1977–1987. Acta Psychiatr Scand 84: 428–434PubMedGoogle Scholar
  168. 167.
    Tauscher J, Neumeister A, Fischer P, Frey R, Kasper S (1997) [Electroconvulsive therapy in clinical practice]. Nervenarzt 68: 410–416Google Scholar
  169. 168.
    Taylor M A, Abrams R (1977) Catatonia. Prevalence and importance in the manic phase of manic-depressive illness. Arch Gen Psychiatry 34: 1223–1225Google Scholar
  170. 169.
    Tew J D Jr, Mulsant B H, Haskett R F, Prudic J, Thase M E, Crowe R R, Dolata D, Begley A E, Reynolds C F Ill, Sackeim H A (1999) Acute efficacy of ECT in the treatment of major depression in the old-old. Am J Psychiatry 156: 1865–1870PubMedGoogle Scholar
  171. 170.
    Thase M E, Friedman E S, Howland R H (2000) Venlafaxine and treatment-resistant depression. Depress Anxiety 12 [Suppl] 1: 55–62Google Scholar
  172. 171.
    van Waarde J A, Stek M L (2001) [Electroconvulsive therapy effective and safe in 55 patients aged 56 years and older with mood disorders and physical comorbidity]. Ned Tijdschr Geneeskd 145: 1693–1697Google Scholar
  173. 172.
    Warneke L (1993) Managing resistant depression. When patients do not respond to therapy. Can Fam Physician 39: 843–850PubMedGoogle Scholar
  174. 173.
    Weiner R D, Coffey C E, Folk J, Fochtmann L J, Greenberg R M, Isenberg K E, Kellner C H, Sackeim H A, Moench L M (2001) The Practice of Electroconvulsive Therapy. American Psychiatric Association, WashingtonGoogle Scholar
  175. 174.
    Weiner R D, Rogers H J, Davidson J R, Kahn E M (1986) Effects of electroconvulsive therapy upon brain electrical activity. Ann N Y Acad Sci 462: 270–281PubMedGoogle Scholar
  176. 175.
    Weiner R D, Rogers H J, Davidson J R, Squire L R (1986) Effects of stimulus parameters on cognitive side effects. Ann N Y Acad Sci 462: 315–325PubMedGoogle Scholar
  177. 176.
    Wesner R B, Winokur G (1989) The influence of age on the natural history of unipolar depression when treated with electroconvulsive therapy. Eur Arch Psychiatry Neurol Sci 238: 149–154PubMedGoogle Scholar
  178. 177.
    West E D (1981) Electric convulsion therapy in depression: a double-blind controlled trial. Br Med J (Clin Res Ed) 282: 355–357Google Scholar
  179. 178.
    Wolfersdorf M, Barg T, Konig F, Leibfarth M, Grunewald I (1995) Paroxetine as antidepressant in combined antidepressant-neuroleptic therapy in delusional depression: observation of clinical use. Pharmacopsychiatry 28: 56–60PubMedGoogle Scholar
  180. 179.
    World Health Organization (1992) The ICD-10 Classification of Mental and Behavioural Disorders: Clinical Descriptions and Diagnostic Guidelines. Geneva, SwitzerlandGoogle Scholar
  181. 180.
    Yatham L N, Kusumakar V, Parikh S V, Haslam D R, Matte R, Sharma V, Kennedy S (1997) Bipolar depression: treatment options. Can J Psychiatry 42 [Suppl] 2: 87S-91 SGoogle Scholar
  182. 181.
    Zimmerman M, Coryell W, Pfohl B (1985) The treatment validity of DSM-III melancholic subtyping. Psychiatry Res 16: 37–43PubMedGoogle Scholar
  183. 182.
    Zimmerman M, Coryell W, Stang] D, Pfohl B (1986) An American validation study of the Newcastle scale. Ill. Course during index hospitalization and six-month prospective follow-up. Acta Psychiatr Scand 73: 412–415Google Scholar
  184. 183.
    Zorumski C F, Rutherford J L, Burke W J, Reich T (1986) ECT in primary and secondary depression. J Clin Psychiatry 47: 298–300PubMedGoogle Scholar
  185. 1.
    Abou-Saleh MT, Coppen AJ (1988) Continuation therapy with antidepressants after electroconvulsive therapy. Convuls Ther 4: 263–268PubMedGoogle Scholar
  186. 2.
    Adli M, Baethge C, Langlitz N, Bauer M. High-dose antidepressant treatment in refractory major depression: a critical review (eingereicht)Google Scholar
  187. 3.
    Adli M, BerghöferA, Linden M, Heimchen H, Müller-Oerlinghausen B, MackertA, Stamm T, Bauer M (2002) Effectiveness and feasibility of a standardized stepwise drug treatment algorithm for inpatients with depressive disorders — results of a two-year observational study. J CI in Psychiatry 63: 782–790Google Scholar
  188. 4.
    Adli M, Kießlinger U, Smolka M, Linden M, Neu P, Bauer M (2001) Algorithm-guided treatment of depression compared to standard treatment as usual — results of a randomized controlled trial in depression. 22. AGNP-Symposium, September 26–29,2001, Nürnberg. Pharmacopsychiatry 34: 162Google Scholar
  189. 5.
    American Psychiatric Association (2000) Practice guidelines for the treatment of patients with major depressive disorder (revision). Am J Psychiatry 157 [Suppl]: 1–45Google Scholar
  190. 6.
    American Psychiatric Association Committee on ElectroconvulsiveTherapy (2001)The Practice of Electroconvulsive Therapy: Recommendations for Treatment, Training, and Privileging. 2nd edn. American Psychiatric Association, Washington, DCGoogle Scholar
  191. 7.
    Amsterdam JD (1991) Use of high dose tranylcypromine in resistant depression. In: Amsterdam JD (Hrsg) Advances in Neuropsychiatry and Psychopharmacology. Vol 2: Refractory depression. Raven Press, New York, pp 123–129Google Scholar
  192. 8.
    Amsterdam JD, Hornig-Rohan M (1996)Treatment algorithms in treatment-resistant depression. Psychiatr Clin North Am 19: 371–386Google Scholar
  193. 9.
    Anderson DN (1994) Early responses to electroconvulsive therapy [letter]. Br J Psychiatry 165: 119–120PubMedGoogle Scholar
  194. 10.
    Andrade C, Gangadhar BN, Swaminath G, Channabasavanna SM (1988) Predicting the outcome of endogenous depression following electronconvulsive therapy. Convuls Ther 4: 169–174PubMedGoogle Scholar
  195. 11.
    Aronson R, Offman HJ, Joffe RT, Naylor D (1996) Triiodothyronine augmentation in the treatment of refractory depression. A meta-analysis. Arch Gen Psychiatry 53: 842–848Google Scholar
  196. 12.
    Aronson TA, Shukla S, Hoff A (1987) Continuation therapy after ECT for delusional depression: a naturalistic study of prophylactic treatments and relapse. Convuls Ther 3: 251–259PubMedGoogle Scholar
  197. 13.
    Avery D, Lubrano A (1979) Depression treated with imipramine and ECT: the DeCarolis study reconsidered. Am J Psychiatry 136: 549–562Google Scholar
  198. 14.
    Bauer M, Döpfmer S (1999) Lithium augmentation in treatment-resistant depression — a meta-analysis of placebo-controlled studies. J CI in Psychopharmacol 19: 427–434Google Scholar
  199. 15.
    Bauer M, Forsthoff A, Baethge C, Adli M, BerghöferA, Döpfiner S, BschorT. Lithium augmentation therapy in refractory depression — update 2002 (eingereicht)Google Scholar
  200. 16.
    Bauer M, Hellweg R, Baumgartner A (1998a) Hochdosierte Thyroxinbehandlung bei therapieund prophylaxeresistenten Patienten mit affektiven Psychosen. Nervenarzt 69: 1019–1022PubMedGoogle Scholar
  201. 17.
    Bauer M, Hellweg R, Gräf KJ, Baumgartner A (1998b) Treatment of refractory depression with high-dose thyroxine. Neuropsychopharmacology 18: 444–455PubMedGoogle Scholar
  202. 18.
    Bauer M, Heimchen H (2000) Allgemeine Behandlungsprinzipien bei affektiven Störungen. In: Heimchen H, Henn F, Lauter H, Sartorius N (Hrsg) Psychiatrie der Gegenwart, Bd. 5: Schizophrene und affektive Störungen. Springer, Berlin Heidelberg, S 475–493Google Scholar
  203. 19.
    Bauer M, Whybrow PC, Angst J, Versiani M, Möller HJ (2002) World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for Biological Treatment of Unipolar Depressive Disorders, Part 1: Acute and Continuation Treatment of Major Depressive Disorder. World J Biol Psychiatry 3: 5–43Google Scholar
  204. 20.
    Bauer M, Whybrow PC, Angst J, Versiani M, Möller HJ (2002) World Federation of Societies of Biological Psychiatry (WFSBP): Guidelines for Biological Treatment of Unipolar Depressive Disorder, Part 2: MaintenanceTreatment of Major Depressive Disorder and Treatment of Chronic Depressive Disorders and Subthreshold Depressions. World J Biol Psychiatry 3: 67–84Google Scholar
  205. 21.
    Benbow SM (1989)The role of electroconvulsive therapy in the treatment of depressive illness in old age. Br J Psychiatry 155: 147–152Google Scholar
  206. 22.
    BerghöferA, Müller EB, Bauer M, Linden M, MackertA, Müller-Oerlinghausen B, Heimchen H (1997) Sequentiel le Behandlungsstrategien zur Vermeidung und Überwindung von Therapieresistenz bei depressiven Erkrankungen. In: Bauer M, Berghöfer A (Hrsg) Therapieresistente Depressionen. Aktueller Wissensstand and Leitlinien für die Behandlung in Klinik and Praxis. Springer, Berlin Heidelberg New York, S 235–243Google Scholar
  207. 23.
    Black DW; Winokur G, Nasrallah A (1987) The treatment of depression: electroconvulsive therapy v antidepressants: a naturalistic evaluation of 1,495 patients. Compr Psychiatry 28: 169–182PubMedGoogle Scholar
  208. 24.
    Bourgon LN, Kellner CH (2000) Relapse of depression after ECT: a review. J ECT 16: 19–31Google Scholar
  209. 25.
    Bourne H (1954) Convulsion dependence. Lancet 2: 1193–1196Google Scholar
  210. 26.
    Brandon S, Cowley P, McDonald C, Neville P, Palmer R, Wellstood-Eason S (1984) Electroconvulsive therapy: results in depressive illness from the Leceisthershire trial. BMJ 288: 22–25Google Scholar
  211. 27.
    Bratfos O, Haug JO (1965) Electroconvulsive therapy and antidepressant drugs in manic-depressive disease. Treatment results at discharge and 3 months later. Acta Psychiatr Scand 41: 588–596.PubMedGoogle Scholar
  212. 28.
    Buchan H, Johnstone E, McPherson K, Palmer RL, Crow TJ, Brandon S (1992) Who benefits from electroconvulsive therapy ? Combined results of the Leicester and Northwick Park trials. Br J Psychiatry 160: 335–359Google Scholar
  213. 29.
    Clarke TB, Coffey CE, Hoffmann GW, Weiner RD (1989) Continuation therapy for depression using outpatient electroconvulsive therapy. Convuls Ther 5: 330–337PubMedGoogle Scholar
  214. 30.
    Coppen A, Abou-Saleh MT, Milln P, Bailey), Metcalfe M, Burns BH, Armond A (1981) Lithium continuation therapy following electroconvulsive therapy. Br J Psychiatry 139: 284–287PubMedGoogle Scholar
  215. 31.
    Coryell W (2000) Augmentation strategies for inadequate antidepressant response: a review of placebo-controlled studies. Ann Clin Psychiatry 12: 141–146PubMedGoogle Scholar
  216. 32.
    Coryell W, Akiskal HS, Leon AC, Winokur G, Maser JD, Mueller TI, Keller MB (1994) The time course of non-chronic major depressive disorder. Arch Gen Psychiatry 51: 405–410PubMedGoogle Scholar
  217. 33.
    Coryell W, Zimmermann M (1983)The dexamethasone suppression test and ECT outcome: a six-month follow-up. Biol Psychiatry 18: 21–27Google Scholar
  218. 34.
    Cosgriff JP, Abbott RM, Oakley-Browne MA, Joyce PR (1990) Cortisol hypersecretion predicts early depressive relapse after recovery with electroconvulsive therapy. Biol Psychiatry 28: 1007–1010PubMedGoogle Scholar
  219. 35.
    Danish University Antidepressant Group [DUAL] (1999) Clomipramine dose-effect study in patients with depression: clinical end points and pharmacokinetics. Clin Pharmacol Ther 66: 152–165Google Scholar
  220. 36.
    Davidson J, McLeod M, Law-Yone B, Linnoila M (1978) A comparison of electroconvulsive therapy and combined phenelzin-amitriptyline in refractory depression. Arch Gen Psych 35: 639–642Google Scholar
  221. 37.
    DeBattista C, Mueller K (2001) Is electroconvulsive therapy effective for the depressed patient with comorbid borderline personality disorder ? J ECT 17: 91–98Google Scholar
  222. 38.
    DeCarolis V, Giberti F, Roccataglia G (1964) Imipramina ed elettroshock nella terapia delle depressioni: analisi clinico-statisica dei risutanti in 437 casi. Sistema Nervosa 1: 28–42Google Scholar
  223. 39.
    Decina P, Guthrie EB, Sackeim HA, Kahn D, Malitz 5 (1987a) Continuation ECT in the management of relapses of major affective episodes. Acta Psychiatr Scand 75: 559–562Google Scholar
  224. 40.
    Decina P, Sackeim HA, Kahn DA, Pierson D, Hopkins N, Malitz S (1987b) Effects of ECT on the TRH stimulation test. Psychoneuroendocrinology 12: 29–34PubMedGoogle Scholar
  225. 41.
    Deutsche Gesellschaft für Psychiatrie, Psychotherapie and Nervenheilkunde (DGPPN) (2000) Praxisleitlinien in Psychiatrie and Psychotherapie; Band 5: Behandlungsleitlinie Affektive Erkrankungen, Steinkopff, DarmstadtGoogle Scholar
  226. 42.
    Devanand DP, Sackeim HA, Prudic J (1991) Electroconvulsive therapy in the treatment-resistant patient. Psychiatr Clin North Am14: 905–923Google Scholar
  227. 43.
    Dinan TG, Barry S (1989) A comparison of electroconvulsive therapy with a combined lithium and tricyclic combination among depressed tricyclic nonresponders. Acta Psychiatr Scand 80: 97–100PubMedGoogle Scholar
  228. 44.
    Dunn CG, Quinlan D (1978) Indicators of ECT response and non-response in the treatment of depression. J Clin Psychiatry 39: 620–622PubMedGoogle Scholar
  229. 45.
    Fink M (2001) Electroconvulsive therapy in medication-resistant depression. In: Amsterdam J, Hornig M, NierenbergA (eds) Treatment-resistant mood disorders. Cambridge University Press, Cambridge, pp 223–238Google Scholar
  230. 46.
    Fink M, Gujavarty K, Greenberg L (1987) Serial dexamethasone suppression tests and clinical outcome in ECT. ConvulsTher 3: 111–120Google Scholar
  231. 47.
    Fink M (1979) Convulsive Therapy: Theory and Practice. Raven Press, New YorkGoogle Scholar
  232. 48.
    Flint AJ (1997) The impact of treatment resistance on depressive relapse following electroconvulsive therapy. Acta Psych iatr Scand 96: 405–406Google Scholar
  233. 49.
    Flint AJ, Rifat SL (1998) The treatment of psychotic depression in later life: a comparison of pharmacotherapy and ECT. Int J Geriatr Psychiatry 13: 23–28PubMedGoogle Scholar
  234. 50.
    Folkerts H (1995) Elektrokrampftherapie—„Schocktherapie” oder ein differenziertes Behand I ungsverfahren. Deutsches Ärzteblatt 92: A358–364Google Scholar
  235. 51.
    Folkerts H (1997) Der Stellenwert der Elektrokrampftherapie b ei therapieresistenten Depressionen. In: Bauer M, Berghöfer A (Hrsg)Therapieresistente Depressionen. Aktueller Wissensstand und Leitlinien für die Behandlung in Klinik und Praxis. Springer, Berlin Heidelberg New York, S 187–197Google Scholar
  236. 52.
    Folkerts H (1998) Elektrokrampftherapie — Monitoring, Effektivität und pathischer Aspekt. Monographien aus dem Gesamtgebiet der Psychiatrie. Springer, Berlin, Heidelberg, New YorkGoogle Scholar
  237. 53.
    Folkerts H, Tölle MN, Schonauer K, Mücke S, Schulze-Winking H (1997) Electroconvulsive therapy vs. paroxetine in treatment-resistant depression — a randomized study. Acta Psychiatr Scand 96: 334–342PubMedGoogle Scholar
  238. 54.
    Fraser RM, Glass IB (1980) Unilateral and bilateral ECT in elderly patients: a comparative study. Acta Psychiatar Scand 62: 13–31Google Scholar
  239. 55.
    Freeman CP, Basson JV, Crighton A (1978) Double-blind controlled trial of electroconvulsive therapy ( ECT) and simulated ECT in depressive illness. Lancet 1: 738–740Google Scholar
  240. 56.
    Frey R, Schreinzer D, Heiden A, Kasper S (2001) Einsatz der Elektrokrampftherapie in der Psychiatrie. Nervenarzt 72: 661–676PubMedGoogle Scholar
  241. 57.
    Gaebel W, Falkai P (1996) Entwurf von DGPPN-Leitlinien zur Indikation und Durchführung der Elektrokrampftherapie ( EKT ). Nervenarzt 67: 509–514Google Scholar
  242. 58.
    Gagné GG, Furman MJ, Carpenter LL, Price LH (2000) Efficacy of continuation ECT and antidepressant drugs compared to long-term antidepressants alone in depressed patients. Am J Psychiatry 157: 1960–1965PubMedGoogle Scholar
  243. 59.
    Glass RM (2001) Electroconvulsive Therapy. Time to bring it out of the shadows. JAMA 285: 1346–1348PubMedGoogle Scholar
  244. 60.
    Gregory S, Shawcross CR, Gill D (1985)The Nottingham ECT Study. A double-blind comparison of bilateral, unilateral and simulated ECT in depressive illness. Br J Psychiatry 146: 520–524Google Scholar
  245. 61.
    Grunhaus L, Shipley JE, Eiser A, Pande AC, Tandon R, Remen A, Greden JF (1994) Shortened REM latency post ECT is associated with rapid recurrence of depressive symptomatology. Biol Psychiatry 36: 214–22PubMedGoogle Scholar
  246. 62.
    Gupta S, Austin R, Devanand DP (1998) Lithium and maintenance electroconvulsive therapy. J ECT 14: 241–244Google Scholar
  247. 63.
    Hamilton M (1974) Drug resistant depressions: response to ECT. Pharmakopsychiatrie 7: 205206Google Scholar
  248. 64.
    Hamilton M, White J (1960) Factors related to the outcome of depression treated with ECT. J Ment Sci 106: 1031–1041PubMedGoogle Scholar
  249. 65.
    Heinz A (1997) Experimentelle Behandlungsansätze and Zukunftsperspektiven bei therapieresistenten Depressionen. In: Bauer M, Berghöfer A (Hrsg)Therapieresistente Depressionen. Aktueller Wissensstand and Leitlinien für die Behandlung in Klinik and Praxis. Springer, Berlin Heidelberg New York, S 152–169Google Scholar
  250. 66.
    Heimchen H (1990) Gestuftes Vorgehen bei Resistenz gegen Antidepressiva-Therapie. In: Möller HJ (Hrsg) Therapieresistenz unter Antidepressiva-Behandlung. Springer, Berlin Heidelberg New York, S 237–250Google Scholar
  251. 67.
    Hobson RF (1953) Prognostic factors in ECT. J Neurol Neurosurg Psychiatry 16: 275–281PubMedGoogle Scholar
  252. 68.
    Imlah NW, Ryan E, Harrington JA (1965)The influence of antidepressant drugs on the response to electroconvulsive therapy and on subsequent relapse rates. Neuropsychopharmacology 4: 438–442Google Scholar
  253. 69.
    Janicak PG, Easton M, Comaty JE, Dowd S, David JM (1989) Efficacy of ECT in psychotic and non-psychotic depression. Convuls Ther 5: 314–320PubMedGoogle Scholar
  254. 70.
    Joffe RT, Singer W (1990) A comparison of triiodthyronine and thyroxine in the potentiation of tricyclic antidepressants. Psychiatry Res 32: 241–251PubMedGoogle Scholar
  255. 71.
    Joffe RT, Singer W, Levitt At MacDonald C (1993) A placebo-controlled comparison of lithium and triiodthyronine augmentation of tricyclic antidepressants in unipolar refractory depression. Arch Gen Psychiatry 50: 387–393PubMedGoogle Scholar
  256. 72.
    Johnstone EC, Deakin JF, Lawler P, Frith CD, Stevens M, McPherson K (1980)The Northwick Park electroconvulsive therapy trial. Lancet 2: 1317–1320Google Scholar
  257. 73.
    Katona CLE, Aldridge CR (1984) Prediction of ECT response. Neuropharmacology 23: 281–283PubMedGoogle Scholar
  258. 74.
    Katona CLE, Aldridge CR, Roth M, Hyde J (1987) The dexamethasone suppression test and prediction of outcome in patients receiving ECT. Br J Psychiatry 150: 315–318PubMedGoogle Scholar
  259. 75.
    Kay DWK, Kahy T, Garside RF (1970) A 7-month double-blind trial of amitriptyline and diazepam in ECT-treated depressed patients. Br J Psychiatry 117: 667–671PubMedGoogle Scholar
  260. 76.
    Kindler S, Shapira B, Hadjez J, Abramowitz M, Brom D, Lerer B (1991) Factors influencing response to bilateral electroconvulsive therapy in major depression. ConvulsTher 7: 245–254Google Scholar
  261. 77.
    Kirkegaard C, Norlem N, Lauridsen UB, Bjorum N, Christiansen C (1975) Protirelin stimulation test and thyroid function during treatment of depression. Arch Gen Psychiatry 32: 1115–1118PubMedGoogle Scholar
  262. 78.
    Kroessler D (1985) Relative efficacy rates for therapies of delusiohnal depression. Convuls Ther 1: 173–182PubMedGoogle Scholar
  263. 79.
    Krog-Meyer I, Kirkegaard C, Kijne B, Lumholtz B, Smith E, Lykke-Olesen L, Bjorum N (1984) Prediction of relapse with the TRH test and prophylactic amitriptyline in 39 patients with endogenous depression. Am J Psychiatry 141: 945–948PubMedGoogle Scholar
  264. 80.
    Kukopulos A, Reginaldi D, Tondo L, Bernabei A, Caliari B (1977) Spontaneuous length of depression and response to ECT. Psycho) Med 7: 625–629Google Scholar
  265. 81.
    Landen M, Bjorling G, Agren H, Fahlen T (1998) A randomized, double-blind, placebo-controlled trial of buspirone in combination with an SSRI in patients with treatment-refractory depression. J Clin Psychiatry 59: 664–668PubMedGoogle Scholar
  266. 82.
    Lauritzen L, Odgaard K, Clemmesen L, Lunde M, Ohrstrom J, Black C, Bech P (1996) Relapse prevention by means of paroxetine in ECT-treated patients with major depression: a comparison with imipramine and placebo in medium-term continuation therapy. Acta Psychiatr Scand 94: 241–51PubMedGoogle Scholar
  267. 83.
    Linden M, Heimchen H, MackertA, MüIIer-Oerlinghausen B (1994) Structure and feasibility of a standardized stepwise drug treatment regimen ( SSTR) for depressed inpatients. Pharmacopsychiat 27: 51–53Google Scholar
  268. 84.
    Lipman RS, Uffner W, Schwalb N, Ravetz R, Lief B, Levy S, Levenberg D (1986) Dexamethasone suppression test as a predictor of response to electroconvulsive therpay. II: Six-month follow-up. ConvulsTher 2: 161–167Google Scholar
  269. 85.
    Magni G, Fisman M, Helmes E (1988) Clinical correlates of ECT-resistant depression in the elderly. J Clin Psychiatry 49: 405–407PubMedGoogle Scholar
  270. 86.
    Mandel MR (1975) Electroconvulsive therapy for chronic pain associated with depression. Am J Psychiatry 132: 632–636PubMedGoogle Scholar
  271. 87.
    Mandel MR, Welch CA, Mieske M (1977) Prediction of response to ECT in tricyclic-intolerant or tricyclic-resistant depressed patients. McLean Hosp J 2: 203–209Google Scholar
  272. 88.
    Markowitz), Brown R, Sweeney), Mann JJ (1987) Reduced length and cost of hospital stay for major depression in patients treated with ECT. Am J Psychiatry 144: 1025–1029PubMedGoogle Scholar
  273. 89.
    McCall WV (2001) Electroconvulsive therapy in the era of modern psychopharmacology. Int J Neuropsychopharmacol 4: 315–324PubMedGoogle Scholar
  274. 90.
    McCall WV, Reboussin DM, Weiner RD, et al (2000)Titrated moderately suprathreshold vs fixed high-dose right unilateral electroconvulsive therapy: acute antidepressant and cognitive effects. Arch Gen Psychiatry 57: 438–444Google Scholar
  275. 91.
    McCall WV, Reid S, Rosenquist P, Foreman A, Kiesow-Webb N (1993) A reappraisal of the role of caffeine in ECT. Am J Psychiatry 50: 1543–1545Google Scholar
  276. 92.
    McDonald WM, McCall WV, Epstein CM (2002) Electroconvulsive therapy: sixty years of progress and a comparison with transcranial magnetic stimulation and vagal nerve stimulation. In: Davis KL, Charney D, Coyle JT, Nemeroff C (eds) Neuropsychopharmacology: the fifth generation of progress: an official publication of the American College of Neuropsychopharmacology, Williams Wilkins, Ort, pp 1097–1108Google Scholar
  277. 93.
    Medical Research Council (1965) Clinical trial of the treatment of depressive illness. BMJ 5439: 881–886Google Scholar
  278. 94.
    Möller HJ (1997) Therapieresistenz unter Antidepressiva: Definition, Epidemiologie and Risikofaktoren. In: Bauer M, Berghöfer A (Hrsg) Therapieresistente Depressionen. Springer, Berlin Heidelberg New York, S 3–15Google Scholar
  279. 95.
    Nemeroff CB, Evans DL (1984) Correlations between the dexamethasone suppression test in depressed patients and clinical response. Am J Psychiatry 141: 247–249PubMedGoogle Scholar
  280. 96.
    Nierenberg AA, Amsterdam JD (1990)Treatment-resistant depression: definition and treatment approaches. J Clin Psychiatry 51 [6, suppll: 39–47Google Scholar
  281. 97.
    Nierenberg AA, Dougherty D, Rosenbaum JF (1998) Dopaminergic agents and stimulants as antidepressant augmentation strategies. J Clin Psychiatry 59 [5, Suppl]: 60–63.PubMedGoogle Scholar
  282. 98.
    Nobler MS, Sackeim HA (1996) Prediction of response to electroconvulsive therapy: clinical and biological aspects. In: Goodnick P (ed) Electroconvulsive therapy: clinical and biological aspects. Predictors of treatment response in mood disorders. American Psychiatric Press, Washington DC, pp 177–198Google Scholar
  283. 99.
    Nobler MS, Sackeim HA (2000) Elektrokrampftherapie. In: Heimchen H, Henn F, Lauter H, Sartorius N (Hrsg) Psychiatrie der Gegenwart, Bd. 5: Schizophrene and affektive Störungen. Springer, Berlin Heidelberg New York, S 683–700Google Scholar
  284. 100.
    Nolen WA (1989) Tranlycypromine in depression resistant to cyclic antidepressants. Prog Neuro-Psychopharmacol Biol Psychiatr 13: 155–158Google Scholar
  285. 101.
    O’Leary DA, Lee AS (1996) Seven years prognosis in depression mortality and readmission risk in the Nottingham ECT cohort. Br J Psychiatry 169: 423–429PubMedGoogle Scholar
  286. 102.
    O’Leary DA, Gill D, Gregory S, et al (1995) Which depressed patients respond to ECT ? The Nottingham results. J Affect Disord 33: 245–250PubMedGoogle Scholar
  287. 103.
    Olfson M, Marcus S, Sackeim HA, Thompson J, Pincus HA (1998) Use of ECT for the ipatient treatment of recurrent major depression. Am J Psychiatry 155: 22–29PubMedGoogle Scholar
  288. 104.
    Pande AC, Krugler T, Haskett RF, Greden JF, Grunhaus LJ (1988) Predictors of response to electroconvulsive therapy in major depression. Biol Psychiatry 24: 91–93PubMedGoogle Scholar
  289. 105.
    PapakostasY, Fink M, Lee J, Irwin P, Johnson L (1981) Neuroendocrine measures in psychiatric patients: course and outcome with ECT. Psychiatry Res 4: 55–64Google Scholar
  290. 106.
    Paul SM, Extein I, Calil HM, Potter WZ, Chodoff P, Goodwin FK (1981) Use of ECT with treatment-resistant depressed patients at the National Institute of Mental Health. Am J Psychiatry 138: 486–489PubMedGoogle Scholar
  291. 107.
    Pearlman C (1987) High dose tranylcypromine in refractory depression [letter]. J Clin Psychiatry 48: 423–424Google Scholar
  292. 108.
    Perez V, Soler J, Puigdemont D, Alvarez E, Artigas F (1999) A double-blind, randomized, placebo-controlled trial of pindolol augmentation in depressive patients resistant to serotonin reuptake inhibitors. Arch Gen Psychiatry 56: 375–379PubMedGoogle Scholar
  293. 109.
    Perry P, Tsuang MT (1979) Treatment of unipolar depression following electroconvulsive therapy. J Affect Disord 1: 123–129PubMedGoogle Scholar
  294. 110.
    Post RM, UhdeTW, Rubinow DR, HugginsT (1987) Differential time course for antidepressant effects after sleep deprivation, ECT, and carbamazepine: clinical and theoretical impllications. Psychiat Res 22: 11–19Google Scholar
  295. 111.
    Prudic J, Haskett RF, Mulsant B, Malone KM, Pettinati HM, Stephens S, Greenberg R, Rifas SL, Sackeim HA (1996) Resistance to antidepressant medications and short-term clinical response to ECT. Am J Psychiatry 153: 985–992PubMedGoogle Scholar
  296. 112.
    Prudic J, Sackeim H (1990) Refractory depression and electroconvulsive therapy. In: Roose S, Glassman A (eds) Treatment of Refractory Depression. American Psychiatric Press, Washington, pp 109–128Google Scholar
  297. 113.
    Prudic J, Sackeim HA (1999) Electroconvulsive therapy and suicide risk. J Clin Psychiatry 60 [Suppl 2]: 104–110PubMedGoogle Scholar
  298. 114.
    Prudic J, Sackeim HA, Devanand DP (1990) Medication resistance and clinical response to electroconvulsive therapy. Psychiatric Res 31: 287–296Google Scholar
  299. 115.
    Prudic J, Sackeim HA, Devanand DP, Kiersky JE (1993) The efficacy of ECT in double depression. Depression 1: 38–44Google Scholar
  300. 116.
    Rabheru K, Persad E (1997) A review of continuation and maintenance electroconvulsive therapy. Can J Psychiatry 42: 476–484PubMedGoogle Scholar
  301. 117.
    Rodger CR, Scott Al, Whalley LJ (1994) Is there a delay in the onset of the antidepressant effect of electroconvulsive therapy? Br J Psychiatry 164: 106–109PubMedGoogle Scholar
  302. 118.
    Rush AJ, Crismon ML, Toprac MG, Trivedi MH, Rago WV, Shon SP, Altshuler KZ (1998) Consensus guidelines in the treatment of major depressive disorder. J Clin Psychiatry 59 [20, Suppl]: 73–84PubMedGoogle Scholar
  303. 119.
    Sackeim HA, Decina P, Kanzler M, Kerr B, Malitz S (1987) Effects of electrode placement on the efficacy of titrated low-dose ECT. Am J Psychiatry 144: 1449–1455PubMedGoogle Scholar
  304. 120.
    Sackeim HA, Haskett RF, Mulsant BH, Thase ME, Mann JJ, Pettinati Hm, Greenberg RM, Crowe RR, Cooper TB, Prudic J (2001) Continuation pharmacotherapy in the prevention of relapse following electroconvulsive therapy. JAMA 285: 1299–1307PubMedGoogle Scholar
  305. 121.
    Sackeim HA, Prudic J, Devanand DP, Decina P, Kerr B, Malitz S (1990) The impact of medication resistance and continuation pharmacotherapy on relapse following response to electroconvulsive therapy in major depression. J Clin Psychopharmacol 10: 96–104PubMedGoogle Scholar
  306. 122.
    Sackeim HA, Prudic J, Devanand DP, Nobler MS, Lisanby SH, Peyser S, Fitzsimons L, Moody BJ, Clark MA (2000) A prospective, randomized, double-blind comparison of bilateral and right unilateral electroconvulsive therapy at different stimulus intensities. Arch Gen Psychiatry 57: 425–434PubMedGoogle Scholar
  307. 123.
    Sareen J, Enns MW, Guertin JE (2000)The impact of clinically diagnosed personality disorders on acute and one-year outcomes of electroconvulsive therapy. J ECT 16: 43–51Google Scholar
  308. 124.
    Schmauß M (1996) HochdosierteTranylcyprominbehandlung „therapieresistenter“ Depressionen. Nervenarzt 67: 390–393PubMedGoogle Scholar
  309. 125.
    Schweitzer I, Maguire KP, Gee AH, Tiller JWG, Biddle N, Davies B (1987) Prediction of outcome in depressed patients by weekly monitoring with the dexamethasone suppression test. Br J Psychiatry 151: 780–784PubMedGoogle Scholar
  310. 126.
    Seager CR, Bird RL (1962) Imipramine with electrical treatment in depression — a controlled trial. J Ment Sci 108: 704–707PubMedGoogle Scholar
  311. 127.
    Shapira B, Gorfine M, Lerer B (1995) A prospective study of lithium continuation therapy in depressed patients who have responded to electroconvulsive therapy. Convuls Ther 11: 80–85PubMedGoogle Scholar
  312. 128.
    Shiah IS, Yatham LN, Srisurapantont M, Lam RW, Tam EM, Zis AP (2000) Does the addition of pindolol accelerate the response to electroconvulsive therapy in patients with major depression? A double blind, placebo-controlled pilot study. J Clin Psychopharmacol 20: 373378Google Scholar
  313. 129.
    Simpson GM, Lee JH, Cuculic Z, Kellner R (1976) Two dosages of imipramine in hospitalized endogenous and neurotic depressives. Arch Gen Psychiatry 33: 1093–1102PubMedGoogle Scholar
  314. 130.
    Sobin C, Prudic J, Devanand DP, Nobler MS, Sackeim HA (1996) Who responds to electroconvulsive therapy? A comparison of effective and ineffective forms of treatment. Br J Psychiatry 169: 322–328PubMedGoogle Scholar
  315. 131.
    Sobin C, Sackeim HA, Prudic J, Devanand DP (1995) Predictors of retrograde amnesia following ECT. Am J Psychiatry 152: 995–1001PubMedGoogle Scholar
  316. 132.
    Solan WJ, Khan A, Avery D, Cohen S (1988) Psychotic and non-psychotic depression: comparison of response to ECT. J Clin Psychiatry 49: 97–99PubMedGoogle Scholar
  317. 133.
    Souery D, Lipp O, Massat I, Mendlewicz J (2001) The characterization and definition of treatment-resistant mood disorders. In: Amsterdam J, Hornig M, Nierenberg AA (eds) Treatment-resistant mood disorders. Cambridge University Press, Cambridge, pp 3–29Google Scholar
  318. 134.
    Spiker DG, Stein J, Rich CL (1985) Delusional depression and electroconvulsive therapy: one year later. Convuls Ther 1: 167–182PubMedGoogle Scholar
  319. 135.
    Stern RA, Nevels CT, Shelhorse ME, Prohaska ML, Mason GA, Prange AJ (1992) The use of T3 to enhance the effects of ECT. Clin Neuropharmacol 15 [Suppl]: 397A - 288AGoogle Scholar
  320. 136.
    Stevenson GH, Geoghegan JJ (1951) Prophylactic electroshock: a five-year study. Am J Psychiatry 107: 743–74PubMedGoogle Scholar
  321. 137.
    Thase ME, Kupfer DJ, Jarrett DB (1989) Treatment of imipramine-resistant recurrent depression. II. An open clinical trial of adjunctive L-triiodthyronine. J Clin Psychiatry 50: 385–388Google Scholar
  322. 138.
    Thase ME, Rush AJ (1995) Treatment-resistant depression. In: Bloom FE, Kupfer DJ (eds) Psychopharmacology: The Fourth Generation of Progress. Raven Press, New York, pp 10811097Google Scholar
  323. 139.
    Thase ME, Rush Ai (1997) When at first you don’t succeed: sequential strategies for antidepressant nonresponders. J Clin Psychiatry 58 [Suppl] 13: 23–29Google Scholar
  324. 140.
    Thornton J, Mulsant B, Dealy R, Reynolds CF 3rd (1990) A retrospective study of maintenance electroconvulsive therapy in a university based psychiatric practice. Convuls Therapy 6: 121–129Google Scholar
  325. 141.
    Trivedi MH, Rush AJ, Crismon ML, Key T, KashnerTM, Biggs MM, Shores-Wilson K, Toprac MG, Carmody TJ, Witte B, Pigott, T, Shon SP (2000)TheTexas Medication Algorithm Project (TMAP): outcomes for persons with major depressive disorder [abstract]. 39th Annual Meeting of the American College of Neuropsychopharmacology; Dec. 10–14, 2000; San Juan, Puerto RicoGoogle Scholar
  326. 142.
    Tsutsui S, Yamazaki Y, Namba T, Tsushima M (1979) Combined therapy of T3 and antidepressants in depression. J Int Med Res 7: 138–146PubMedGoogle Scholar
  327. 143.
    Watt DC, Crammer JL, Elkes A (1972) Metabolism, anticholinergic effects, and therapeutic outcome of desmethylimipramine in depressive illness. Psycho) Med 2: 397–405Google Scholar
  328. 144.
    Wetterling T, Michels R, Dilling H (1998) Elektrokrampftherapie bei therapieresistenter Altersdepression. Nervenarzt 69: 617–621PubMedGoogle Scholar
  329. 145.
    Williams JH, O’Brien JT, Cullum S (1997)Time course of response to electroconvulsive therapy in elderly depressed subjects. Int J Geriatr Psychiatry 12: 563–566Google Scholar
  330. 146.
    Wilson IC, Vernon JT, Guin T, Sandifer MG (1962) A control led study of treatments of depression. J Neuropsychiatry 4: 331–332Google Scholar
  331. 147.
    Wolkowitz OM, ReusVl, KeeblerA, Nelson N, Friedland M, Brizendine L, Roberts E (1999) Double-blind treatment of major depression with dehydroepiandrosterone. Am J Psychiatry 156: 646–649.PubMedGoogle Scholar
  332. 148.
    Yerevanian BI, Olafsdottir H, Milanese E, Russotto J, Mallon P, Baciewicz G, Sagi E (1983) Normalization of the dexamethasone suppression test at discharge from hospital. J Affect Disord 5: 191–197PubMedGoogle Scholar
  333. 149.
    Zimmermann M, Coryell W, Pfohl B, Corenthal C, Stangl D (1986) ECT response in depressed patients with and without DSM-III personality disorder. Am J Psychiatry 143: 1030–1032Google Scholar
  334. 150.
    Zweifel JE, O’Brien WH (1997) A meta-analysis of the effect of hormone replacement therapy upon depressed mood. Psychoneuroendocrinology 22: 189–212PubMedGoogle Scholar
  335. 1.
    Angst J (1985) Switch from depression to mania-a record study over decades between 1920 and 1982. Psychopathology 18: 140–154PubMedGoogle Scholar
  336. 2.
    APA (2002) The practice of electroconvulsive therapy: recommendations for treatment, training and privileging: a task force report of the american psychiatric association. American Psychiatric Press, Washington, DCGoogle Scholar
  337. 3.
    Black DW, Winokur G, Nasrallah A (1986) ECT in Unipolar and Bipolar Disorders: A Naturalistic Evaluation of 460 Patients. ConvulsTher 2: 231–237Google Scholar
  338. 4.
    Black DW, Winokur G, Nasrallah A (1987) Treatment of mania: a naturalistic study of electroconvulsive therapy versus lithium in 438 patients. J Clin Psychiatry 48: 132–139PubMedGoogle Scholar
  339. 5.
    Chanpattana W (2000) Combined ECT and clozapine in treatment-resistant mania. J ECT 16: 204–207Google Scholar
  340. 6.
    Ciapparelli A, Dell’Osso L, Tundo A, Pini S, Chiavacci MC, Di S, I, Cassano GB (2001) Electroconvulsive therapy in medication-nonresponsive patients with mixed mania and bipolar depression. J Clin Psychiatry 62: 552–555PubMedGoogle Scholar
  341. 7.
    Clarke TB, Coffey CE, Hoffman GW Jr, Weiner RD (1989) Continuation Therapy for Depression Using Outpatient Electroconvulsive Therapy. ConvulsTher 5: 330–337Google Scholar
  342. 8.
    Daly JJ, Prudic J, Devanand DP, Nobler MS, Lisanby SH, Peyser S, Roose SP, Sackeim HA (2001) ECT in bipolar and unipolar depression: differences in speed of response. Bipolar disorders 3: 95–104PubMedGoogle Scholar
  343. 9.
    Devanand DP, Polanco P, Cruz R, Shah S, Paykina N, Singh K, Majors L (2000) The efficacy of ECT in mixed affective states. J ECT 16: 32–37Google Scholar
  344. 10.
    Dilsaver SC, Chen YW, Swann AC, Shoaib AM, Tsai-Dilsaver Y, Krajewski KJ (1997) Suicidality, panic disorder and psychosis in bipolar depression, depressive-mania and pure-mania. Psychiatry Res 73: 47–56PubMedGoogle Scholar
  345. 11.
    Folkerts H, Bender S, Erkwoh R, Klieser E, Klimke A (1996) Entwurf von DGPPN-Leitlinien zur Indikation and Durchführung der Elektrokrampftherapie ( EKT ). Nervenarzt 67: 509–514Google Scholar
  346. 12.
    Frey R, Schreinzer D, Heiden A, Kasper S (2001) Einsatz der Elektrokrampftherapie in der Psychiatrie. Nervenarzt 72: 661–676PubMedGoogle Scholar
  347. 13.
    Frye MA, Ketter TA, Leverich GS, Huggins T, Lantz C, Denicoff KD, Post RM (2000) The increasing use of polypharmacotherapy for refractory mood disorders: 22 years of study. J Clin Psychiatry 61: 9–15PubMedGoogle Scholar
  348. 14.
    Gagne GG Jr, Furman MJ, Carpenter LL, Price LH (2000) Efficacy of continuation ECT and antidepressant drugs compared to long-term antidepressants alone in depressed patients. Am J Psychiatry 157: 1960–1965PubMedGoogle Scholar
  349. 14a.
    Geddes J (2003) Efficacy and safety of electroconvulsive therapy in depressive disorders: a systematic review and meta-analysis. Lancet 361: 799–808Google Scholar
  350. 15.
    Godemann F, Hellweg R (1997) 20 Jahre erfolglose Rezidivprophylaxe einer bipolar-affektiven Psychose. Nervenarzt 68: 582–585Google Scholar
  351. 16.
    Goldberg JF(2000) Treatment guidelines: current and future management of bipolar disorder. J Clin Psychiatry 61 [Suppli 13:12–18Google Scholar
  352. 17.
    Gruber NP, Dilsaver SC, Shoaib AM, Swann AC (2000) ECT in mixed affective states: a case series. J ECT 16: 183–188Google Scholar
  353. 18.
    Grunze H, Erfurth A, Schäfer M, Amann B, Meyendorf R (1999) Elektrokonvulsionstherapie in der Behandlung der schweren Manie. Nervenarzt 70: 662–667PubMedGoogle Scholar
  354. 19.
    Grunze H, Walden J, Dittmann S, Berger M, Bergmann A, Bräunig P, Dose M, Emrich HE, Gastpar M, Greil W, Möller H-J, Uebelhack R (2002) Psychopharmakotherapie Bipolarer Affektiver Erkrankungen. Nervenarzt 73: 4–17PubMedGoogle Scholar
  355. 20.
    Gupta S, Austin R, Devanand DP (1998) Lithium and maintenance electroconvulsive therapy. J ECT 14: 241–244Google Scholar
  356. 21.
    Hlastala SA, Frank E, Mallinger AG, Thase ME, Ritenour AM, Kupfer DJ (1997) Bipolar depression: an underestimated treatment challenge. Depress Anxiety 5: 73–83PubMedGoogle Scholar
  357. 22.
    Husain MM, Meyer DE, Muttakin MH, Weiner MF (1993) Maintenance ECT for treatment of recurrent mania. Am J Psychiatry 150: 985PubMedGoogle Scholar
  358. 23.
    Jaffe RL, Rives W, Dubin WR, Roemer RA, Siegel L (1991) Problems in Maintenance ECT in Bipolar Disorder: Replacement by Lithium and Anticonvulsants. Convuls Ther 7: 288–294Google Scholar
  359. 24.
    Jha AK, Stein GS, Fenwick P (1996) Negative interaction between lithium and electroconvulsive therapy—a case-control study. Br J Psychiatry 168: 241–243PubMedGoogle Scholar
  360. 25.
    Keck PE, McElroy SL, Tugrul KC, Bennett JA (1993) Valproate oral loading in the treatment of acute mania. J Clin Psychiatry 54: 305–308PubMedGoogle Scholar
  361. 26.
    Klapheke MM (1993) Combining ECT and Antipsychotic Agents: Benefits and Risks. Convuls Ther 9: 241–255PubMedGoogle Scholar
  362. 27.
    Kramer BA (1999) A naturalistic review of maintenance ECT at a university setting. J ECT 15: 262–269Google Scholar
  363. 28.
    Kupchik M, Spivak B, Mester R, Reznik I, Gonen N, Weizman A, Kotler M (2000) Combined electroconvulsive-clozapine therapy. Clin Neuropharmacol 23: 14–16PubMedGoogle Scholar
  364. 29.
    Kupka RW, Nolen WA, Altshuler LL, Denicoff KD, Frye MA, Leverich GS, Keck PE Jr, McElroy SL, Rush AJ, SuppesT, Post RM (2001)The Stanley Foundation Bipolar Network: 2. Preliminary summary of demographics, course of illness and response to novel treatments. Br J Psychiatry 178: 5177–5183Google Scholar
  365. 30.
    Lippmann SB (1994) Can elektroconvulsive therapy be given during lithium treatment. Lithium 5: 205–209Google Scholar
  366. 31.
    McCabe MS, Norris B (1977) ECT versus chlorpromazine in mania. Biol Psychiatry 12: 245–254PubMedGoogle Scholar
  367. 32.
    Miller MC (1995) ECT and mania. Am J Psychiatry 152: 654Google Scholar
  368. 33.
    Milstein V, Small JG, Klapper MH, Small IF, Miller MJ, Kellams JJ (1987) Uni-Versus Bilateral ECT in the Treatment of Mania. ConvulsTher 3: 1–9Google Scholar
  369. 34.
    Mishory A, Yaroslaysky Y, Bersudsky Y, Belmaker RH (2000) Phenytoin as an antimanic anticonvulsant: a controlled study. Am J Psychiatry 157: 463–465PubMedGoogle Scholar
  370. 35.
    Mukherjee S(1 989) Mechanisms oftheAntimanic Effectof ElectroconvulsiveTherapy. Convuls Ther 5:227–243Google Scholar
  371. 36.
    Mukherjee S(1 993) Combined ECT and Lithium Therapy. ConvulsTher 9:274–284Google Scholar
  372. 37.
    Mukherjee S, Sackeim HA, Lee C (1988) Unilateral ECT in the treatment of manic episodes. Convuls Ther 4: 74–80PubMedGoogle Scholar
  373. 38.
    Mukherjee S, Sackeim HA, Schnur DB (1994) Electroconvulsive therapy of acute manic episodes: a review of 50 years’ experience. Am J Psychiatry 151: 169–176PubMedGoogle Scholar
  374. 39.
    Peet M (1994) Induction of mania with selective serotonin re-uptake inhibitors and tricyclic antidepressants. Br J Psychiatry 164: 549–550PubMedGoogle Scholar
  375. 40.
    Penney JF, Dinwiddie SH, Zorumski CF, Wetzel RD (1990) Concurrent and Close Temporal Administration of Lithium and ECT. ConvulsTher 6: 139–145Google Scholar
  376. 41.
    Rabheru K, Persad E (1997) A review of continuation and maintenance electroconvulsive therapy. Can J Psychiatry 42: 476–484PubMedGoogle Scholar
  377. 42.
    Rihmer Z, Kiss K (2002) Bipolar disorders and suicide risk. Clinical Approaches in Bipolar Disorders 1: 15–21Google Scholar
  378. 43.
    Sackeim HA, Prudic J, Devanand DP, Nobler MS, Lisanby SH, Peyser S, Fitzsimons L, Moody BJ, Clark J (2000) A prospective, randomized, double-blind comparison of bilateral and right unilateral electroconvulsive therapy at different stimulus intensities. Arch Gen Psychiatry 57: 425–434PubMedGoogle Scholar
  379. 44.
    Sikdar S, Kulhara P, Avasthi A, Singh H (1994) Combined chlorpromazine and electroconvulsive therapy in mania. Br J Psychiatry 164: 806–810PubMedGoogle Scholar
  380. 45.
    Small JG, Kellams JJ, Milstein V, Small IF (1980) Complications with electroconvulsive treatment combined with lithium. Biol Psychiatry 15: 103–112PubMedGoogle Scholar
  381. 46.
    Small JG, Klapper MH, Kellams JJ, Miller MJ, Milstein V, Sharpley PH, Small IF (1988) Electroconvulsive treatment compared with lithium in the management of manic states. Arch Gen Psychiatry 45: 727–732PubMedGoogle Scholar
  382. 47.
    Small JG, Klapper MH, MilsteinV, Marhenke JD, Small IF (1996) Comparison of therapeutic modalities for mania. Psychopharmacol Bull 32: 623–627Google Scholar
  383. 48.
    Small JG, Small IF, MilsteinV, KellamsJJ, Klapper MH (1985) Manic symptoms: an indication for bilateral ECT. Biol Psychiatry 20: 125–134Google Scholar
  384. 49.
    Standish-Barry HM, Deacon V, Snaith RP (1985) The relationship of concurrent benzodiazepine administration to seizure duration in ECT. Acta Psychiatr Scand 71: 269–271PubMedGoogle Scholar
  385. 50.
    Strömgren LS (1988) Electroconvulsive therapy in Aarhus,Denmark, in 1984: its application in non-depressivedisorders. Convuls Ther 4: 306–313Google Scholar
  386. 51.
    Strömgren LS, Dahl J, Fjeldborg N, Thomsen A (1980) Factors influencing seizure duration and number of seizures applied in unilateral electroconvulsive therapy. Anaesthetics and benzodiazepines. Acta Psychiatr Scand 62: 158–165Google Scholar
  387. 52.
    Suppes T, Webb A, Paul B, Carmody T, Kraemer H, Rush Al (1999) Clinical outcome in a randomized 1-year trial of clozapine versus treatment as usual for patients with treatment-resistant illness and a history of mania. Am J Psychiatry 156: 1164–1169PubMedGoogle Scholar
  388. 53.
    Swoboda E, Conca A, Konig P, Waanders R, Hansen M (2001) Maintenance electroconvulsive therapy in affective and schizoaffective disorder. Neuropsychobiology 43: 23–28PubMedGoogle Scholar
  389. 54.
    Thomas J, Reddy B (1982)The treatment of mania. A retrospective evaluation of the effects of ECT, chlorpromazine, and lithium. J Affect Disord 4: 85–92Google Scholar
  390. 54a.
    Tohen M (2002) Olanzapine vs placebo for relapse prevention in bipolar disorder. Data presented at the ACNP, Puerto Rico 7–10. 12. 2002Google Scholar
  391. 54.
    b.Tohen M, Marneros A, Bowden C, Calabrese J, Greil W, Koukopoulis A, Belmaker R, Jacobs TG, Robert MAS, Baker RW, Williamson D, Evans AR, Cassano GB (2002) Olanzapine versus lithium in relapse prevention in bipolar disorder: a randomized double-blind controlled 12-month clinical trial. Bipolar Disord 4[Suppl 11: 135Google Scholar
  392. 55.
    Vanelle JM, Loo H, Galinowski A, de Carvalho W, Bourdel MC, Brochier P, Bouvet O, Brochier T, Olie JP (1994) Maintenance ECT in intractable manic-depressive disorders. ConvulsTher 10: 195–205Google Scholar
  393. 56.
    Vieta E, Goikolea JM, Corbella B, Benabarre A, Reinares M, Martinez G, Fernandez A, Colom F, Martinez-Aran A, Torrent C (2001) Risperidone safety and efficacy in the treatment of bipolar and schizoaffective disorders: results from a 6-month, multicenter, open study. J Clin Psychiatry 62: 818–825PubMedGoogle Scholar
  394. 57.
    Vieta E, Reinares M, Corbella B, Benabarre A, Gilaberte I, Colom F, Martinez-Aran A, Gasto C, Tohen M (2001) Olanzapine as long-term adjunctive therapy in treatment-resistant bipolar disorder. J Clin Psychopharmacol 21: 469–473PubMedGoogle Scholar
  395. 1.
    Aboraya A, Schumacher J, Abdalla E, LePage J, McGhee M, Butcher D, Griffin H, Shanda M (2002) Neuroleptic malignant syndrome associated with risperidone and olanzapine in first-episode schizophrenia. WV Med J 98: 63–65Google Scholar
  396. 2.
    Abraham KR, Kulhara P (1987)The efficacy of electroconvulsive therapy in the treatment of schizophrenia. Br J Psychiatry 151: 152–155Google Scholar
  397. 3.
    Abrams R (1994) Elektrokonvulsionstherapie, 2. Auflage. Lake Bluff; Somatics, IncorporatedGoogle Scholar
  398. 4.
    Agel ink MW, Dammers S, Malessa R, Leonhardt M, Zitzelsberger A, Ullrich H, ZeitT (1998) Nutzen und Risiken der Elektrokrampfbehandlung ( EKT) bei älteren Patienten mit kardiovaskulären Risikofaktoren. Nervenarzt 69: 70–75Google Scholar
  399. 5.
    American Psychiatric Association (2001) The practice of ECT: Recommendations for Treatment, Training and Privileging. Am Psychiatric Assoc, Washington DCGoogle Scholar
  400. 6.
    Bailine SH, Rifkin A, Kayne E, Selzer JA, Vital-Herne J, Blieka M, Pollack S (2000) Comparison of bifrontal and bitemporal ECT for major depression. Am J Psychiatry 157: 121–123PubMedGoogle Scholar
  401. 7.
    Bara A (2000) Stellungnahme. Nervenarzt 7: 223–224Google Scholar
  402. 8.
    Batra A, Bartels M, Foerster K (1999) Zur Frage der Genehmigungspflicht von Elektrokrampftherapie im Rahmen einer Betreuung (§1904 BGB). Nervenarzt 70: 657–661PubMedGoogle Scholar
  403. 9.
    Belanoff JK, Flores BH, Kalezhan M, Sund B, Schatzberg AF (2001) Rapid reversal of psychotic depression using mifepristone. J Clin Psychopharmacol 21: 516–521PubMedGoogle Scholar
  404. 10.
    Bottlender R, Jager M, Hofschuster E, Dobmeier P, Moller HJ (2002) Neuroleptic malignant syndrome due to atypical neuroleptics: three episodes in one patient. Pharmacopsychiatry 35: 119–121PubMedGoogle Scholar
  405. 11.
    Brandon S, Cowley P, McDonald C, Neville P, Palmer R, Wellstood-Eason S (1985) Leicester ECT trial-results in schizophrenia. BrJ Psychiatry 146: 177–183Google Scholar
  406. 12.
    Bräunig P, Krüger S, Shugar G (1999) Prävalenz und klinische Bedeutung katatoner Symptome bei Manien. Fortschr Neurol Psychiat 67: 306–317PubMedGoogle Scholar
  407. 13.
    Brüne M, Bräunig P (1999) Stabilität und Variabilität katatoner Symptome im Krankheitslängsschnitt. Nervenarzt 70: 26–30PubMedGoogle Scholar
  408. 14.
    Bush G, Fink M, Petrides G, Dowling F, Francis A (1996) Catatonia. II. Treatment with lorazepam and electroconvulsive therapy. Acta Psychiatr Scand 93: 137–143Google Scholar
  409. 15.
    Cardwell BA, Nakai B (1995) Seizure activity in combined Clozapin and ECT: a retrospective view. ConvulsTher 11: 110–113Google Scholar
  410. 16.
    Caroff SN, Mann SC, Campbell EC, Sullivan KA (2002) Movement disorders associated with atypical antipsychotic drugs. J Clin Psychiatry 63 [Suppl 4]: 12–19PubMedGoogle Scholar
  411. 17.
    Chanpattana W, Buppanharun W, Raksakietisak S, Vaughn McCall W, Somchai Chakrabhand ML (2000) Seizure threshold rise during electroconvulsive therapy in schizophrenic patients. Psychiatry Res 96: 31–40PubMedGoogle Scholar
  412. 18.
    Chanpattana W, Chakrabhand ML (2001) Factors influencing treatment frequency of continuation ECT in schizophrenia. J ECT 17 (3): 190–194Google Scholar
  413. 19.
    Chanpattana W, Chakrabhand ML, Buppanharun W, Sackeim HA (2000) Effects of stimulus intensity on the efficacy of bilateral ECT in schizophrenia: a preliminary study. Biol Psychiatry 48: 222–228PubMedGoogle Scholar
  414. 20.
    Chanpattana W, Chakrabhand ML, Kitaroonchai W, Choovanichvong S, PrasertsukY (1999) Effects of twice-versus thrice-weekly electroconvulsive therapy in schizophrenia. J Med Assoc Thai 82: 477–483Google Scholar
  415. 21.
    Chanpattana W, Chakrabhand ML, Kongsakon R, Techakasem P, Buppanharun W (1999) Short-term effect of combined ECT and neuroleptic therapy in treatment resistant schizophrenia.) ECT 15: 129–139Google Scholar
  416. 22.
    Charlton BG, Kavanau JL (2002) Delirium and psychotic symptoms-an integrative model. Med Hypotheses 58: 24–2 7Google Scholar
  417. 23.
    Childers R (1964) Comparison of four regimes in newly admitted female schizophrenics. Am J Psychiatry 120: 1010–1011PubMedGoogle Scholar
  418. 24.
    Cizaldo BC, Wheaton A (1995) Case study: ECT treatment of a young girl with catatonia. J Am Acad Child Adolesc Psychiatry 34: 332–335Google Scholar
  419. 25.
    Cohen D, Flament M, Taieb O, Thompson C, Basquin M (2000) Electroconvulsive therapy in adolescence. European Child Adolescence Psychiatry 9: 1–6Google Scholar
  420. 26.
    Cohen D, Taieb O, Flament M, Benoit N, Chevret S, Corcos M, Fossati P, Jeammet P, Allilaire J-F, Basquin M (2000) Absence of cognitive impairement at long-term follow-up in adolescents treated with ECT for severe mood disorder. Am J Psychiatry 157: 460–462PubMedGoogle Scholar
  421. 27.
    Conca A, Pycha R, Prapotnik M (2002) Elektrokonvulsionstherapie-Konsensus AG für spezielle biologische Verfahren der ÖGPPGoogle Scholar
  422. 28.
    Conley RR, Kelly DL (2001) Management of treatment resistance in schizophrenia. Biol Psychiatry 50: 898–911PubMedGoogle Scholar
  423. 29.
    Davis JM, Janicak PG, Sakkas P, Gilmore C, Wang Z (1991) Electroconvulsive Therapy in the Treatment of the Neuroleptic Malignant Syndrome. Convuls Ther 7: 111–120PubMedGoogle Scholar
  424. 30.
    Devanand DP, Dwork AJ, Hutchinson ER, Bolwig TG, Sackeim HA (1994) Does ECT alter brain structure? Am J Psychiatry 151: 957–970PubMedGoogle Scholar
  425. 31.
    Dinwiddie SH, Drevets WC, Smith DR (1988) Treatment of Phencyclidine-Associated Psychosis with ECT. Convuls Ther 4: 230–235PubMedGoogle Scholar
  426. 32.
    Dinwiddie SH, Drevets WC, Smith DR (1988) Treatment of Phencyclidine-Associated Psychosis with ECT. Convuls Ther 4: 230–235PubMedGoogle Scholar
  427. 33.
    Dodwell D, Goldberg D (1989) A study of factors associated with response to electroconvulsive therapy in patients with schizophrenic symptoms. Br J Psychiatry 1989 154: 635–639Google Scholar
  428. 34.
    Ende G, Braus DE, Walter S, Weber-Fahr W, Henn F (2000) The hippocampus in patients treated with electroconvulsive therapy. Arch Gen Psychiatry 57: 937–943PubMedGoogle Scholar
  429. 35.
    Fall PA, Ekman R, Granerus AK, Thorell LH, Walinder J (1995) ECT in Parkinson’s desease. Changes in motor symptoms, monoamine metabolites and neuropeptides. J Neural Transm Park Dis Dement Sect 10: 129–140Google Scholar
  430. 36.
    Fink M (1998) ECT and clozapine in schizophrenia [Editorial]. J ECT 14: 223–226Google Scholar
  431. 37.
    Fink M (2001) Catatonia: syndrome or schizophrenia subtype? Recognition and treatment. J Neural Transm 108: 637–644PubMedGoogle Scholar
  432. 38.
    Fink M (2001) Convulsive therapy: a review of the first 55 years. J Affect Disord 63: 1–15PubMedGoogle Scholar
  433. 39.
    Fink M, Taylor MA (2002) Catatonia: A Clinician’s Guide to Diagnosis, Treatment and Neurology. Cambridge University Press, Cambridge, UKGoogle Scholar
  434. 40.
    Fink M, Sackeim HA (1996) Convulsive therapy in schizophrenia? Schizophr Bull 22 (1): 27–39PubMedGoogle Scholar
  435. 41.
    Folkerts H (1995) Elektrokrampftherapie. Dt Ärztebl 92: A-358–364Google Scholar
  436. 42.
    Frankenburg FR, Supps T, McLean PE (1993) Combined Clozapine and electroconvulsive therapy. Convuls Ther 9: 176–180PubMedGoogle Scholar
  437. 43.
    Frey R, Schreinzer D, Heiden A, Kasper S (2001) Einsatz der Elektrokrampftherapie in der Psychiatrie. Nervenarzt 72: 661–676PubMedGoogle Scholar
  438. 44.
    Friedel RO (1986) The combined use of neuroleptics and ECT in drug resistant schizophrenic patients. Psychopharmacol Bull 22: 928–930PubMedGoogle Scholar
  439. 45.
    Gaebel W, Falkai P (1996) Entwurf von DGPPN-Leitlinien zur Indikation and Durchführung der Elektrokrampftherapie ( EKT ). Nervenarzt 67: 509–514Google Scholar
  440. 46.
    Ghaziuddin N, Laughrin D, Giordani B (2000) Cognitive side effects of electroconvulsive therapy in adolescents. J Child Adolesc Psychopharmacol 10: 269–276PubMedGoogle Scholar
  441. 47.
    Grunze H, Erfurth A, Schäfer M, Amann B, Meyendorf R (1999) Elektrokonvulsionsbehandlungstherapie in der Behandlung der schweren Manie. Nervenarzt 70: 662–667PubMedGoogle Scholar
  442. 48.
    Gujavarty K, Greenberg LB, Fink M (1987) Electroconvulsive Therapy and Neuroleptic Medication in Therapy-Resistant Positive-Symptom Psychosis. Convuls Ther 3: 185–195PubMedGoogle Scholar
  443. 49.
    Hafeiz HB (1987) Psychiatric manifestations of enteric fever. Acta Psychiatr Scand 75: 69–73PubMedGoogle Scholar
  444. 50.
    Heils A, Lesch KP (1997) Neuroleptic malignant syndrome and life threatening catatonia-two contrasting disease entities? Fortschr Neurol Psychiatr 65: 8–15PubMedGoogle Scholar
  445. 51.
    Hirose S, Ashby CR, Mills MJ (2001) Effectiveness of ECT combined with risperidone against aggression in schizophrenia. J ECT 17: 22–26Google Scholar
  446. 52.
    Ishihara K, Sasa M (1999) Mechanism underlying the therapeutic effects of electroconvulsive therapy ( ECT) on depression. Jpn J Pharmacol 80: 185–189Google Scholar
  447. 53.
    Janakiramaiah N, Channabasavanna SM, Murthy NS (1982) ECT/chlorpromazine combination versus chlorpromazine alone in acutely schizophrenic patients. Acta Psychiatr Scand 66: 464–470PubMedGoogle Scholar
  448. 54.
    Janicak PG, Davis JM, Gibbons RD, Ericksen S, Chang S, Gallagher P (1985) Efficacy of ECT: a meta-analysis. Am J Psychiatry 14: 297–302Google Scholar
  449. 55.
    Janowsky EC, Risch C, Janowsky DS (1981) Effects of anesthesia on patients taking psychotropic drugs. J Clin Psychopharmacol 1: 14–20PubMedGoogle Scholar
  450. 56.
    Juckel G, Mendlin A, Jacobs BL (1999) Electrical stimulation of rat medial prefrontal cortex enhances forebrain serotonin output: implications for electroconvulsive therapy and trans-cranial magnetic stimulation in depression. Neuropsychopharmacology 21: 391–398PubMedGoogle Scholar
  451. 57.
    Kales HC, Dequardo JR, Tandon R (1999) Combined electroconvulsive therapy and clozapine in treatment resistent schizophrenia. Prog Neuropsychopharmacol Biol Psychiatry 23: 547556Google Scholar
  452. 58.
    Katschnig H, Donat H, Fleischhacker WW, Meise U (2002) 4x8 Empfehlungen zur Behandlung von Schizophrenie. edition pro mente, LinzGoogle Scholar
  453. 59.
    Keck PE Jr, Caroff SN, McElroy SL (1995) Neuroleptic malignant syndrome and malignant hyperthermia: end of a controversy? J Neuropsychiatry Clin Neurosci 7: 135–144PubMedGoogle Scholar
  454. 60.
    Kellner CH (1999) Novel electrode placements: time to reassess (Editorial). J ECT 15: 115–117Google Scholar
  455. 61.
    Klapheke MM (1991) Clozapine, ECT, and schizoaffective disorder, bipolar type. Convuls Ther 7: 36–39PubMedGoogle Scholar
  456. 62.
    Klimke A, Klieser E (1991) [Effectiveness of neuro-electric therapy in drug resistant endogenous psychoses]. Fortschr Neurol Psychiatr 59: 53–59Google Scholar
  457. 63.
    König P, Glatter-Götz U (1990) Combined electroconvulsive and neuroleptic therapy in schizophrenia refractory to neuroleptics. Schizophr Res 3: 351–4PubMedGoogle Scholar
  458. 64.
    Krankenanstaltenrecht (2000) Herausgeber A. Radner, A.Haslinger, P. Reinberg, T. Radner. Rudolf Traum Verlag Linz 2000; 55. Lieferung 2001Google Scholar
  459. 65.
    Krueger RB, Sackeim HA (1995) Electroconvulsive therapy and schizophrenia. In: Hrisch S, Weinberger D (eds) Schizophrenia. Oxford, England. Blackwell, pp 503–545Google Scholar
  460. 66.
    Kupchik M, Spivak B, Mester R, Reznik I, Gonen N, Weizman A, Kotler M (2000) Combined electroconvulsive-clozapine therapy. Clin Neuropharmacol 23: 14–16PubMedGoogle Scholar
  461. 67.
    Landmark J, Joseph L, Merskey H (1987) Characteristics of schizophrenic patients and the outcome of fluphenazine and of electroconvulsive treatments. Can J Psychiatry 32: 425–428PubMedGoogle Scholar
  462. 68.
    Landy DA (1991) Combined use of clozapine and electroconvulsive therapy. Convuls Ther 7: 218–221PubMedGoogle Scholar
  463. 69.
    Lee JWY (1998) Serum iron in catatonia and neuroleptic malignant syndrome. Biol Psychiatry 44: 499–507PubMedGoogle Scholar
  464. 70.
    Letemendia FIJ, Delva NJ, Rodenburg M, Lawson JS, Inglis J, Waldron JJ, Lywood DW (1993) Therapeutic advantage of bifrontal electrode placement in ECT. Psychol Med 23: 349–360PubMedGoogle Scholar
  465. 71.
    Lisanby SH, Bazil CW, Resor SR, Nobler MS, Finck DA, Sackeim HA (2001) ECT in the treatment of status epi lepticus. J ECT 2001 17: 210–215Google Scholar
  466. 72.
    Llorca PM, Chereau I, Bayle FJ, Lancon C (2002) Tardive dyskinesias and antipsychotics: a review. Eur Psychiatry 17: 129–138PubMedGoogle Scholar
  467. 73.
    Mac DS, Pardo MP (1983) Systemic lupus erythematosus and catatonia: a case report. J Clin Psychiatry 44: 155–156PubMedGoogle Scholar
  468. 74.
    Malur C, Francis A (2001) Emergence of catatonia during ECT. J ECT 17: 201–204Google Scholar
  469. 75.
    Mann SC, Auriacombe M, Macfadden W, Caroff SN, Cabrina Campbell E, Tignol J (2001) [Lethal catatonia: clinical aspects and therapeutic intervention. A review of the literature] Encephale 27: 213–216Google Scholar
  470. 76.
    Mann SC, Caroff SN, Bleier HR (1986) Lethal catatonia. Am J Psychiatry 143: 1374–1381PubMedGoogle Scholar
  471. 77.
    Masiar SJ, Johns CA (1991) ECT following clozapine. Br J Psychiatry 158: 135–136PubMedGoogle Scholar
  472. 78.
    May PRA (1968) Treatment of schizophrenia: A comparative study of five treatment methods. New York, Science HouseGoogle Scholar
  473. 79.
    McIntyre R, McCann SM, Kennedy SH (2001) Antipsychotic metabolic effects: weight gain, diabetes mellitus and lipid abnormalities. Can J Psychiatry 46: 273–281PubMedGoogle Scholar
  474. 80.
    Meduna Li (1935) Die Konvulsiontherapie der Schizophrenie. Psychr Neurol Wochenschr 37: 317–319Google Scholar
  475. 81.
    Miller L (1994) Use of electroconvulsive therapy during pregnancy. Hosp Commun Psychiatry 45: 444–450Google Scholar
  476. 82.
    Milstein V, Small JG, Miller MJ, Sharpley PH, Small IF (1990) Mechanisms of action of ECT: schizophrenia and schizoaffective disorder. Biol Psychiatry 27 (12): 1282–1292PubMedGoogle Scholar
  477. 83.
    Mukherjee S, DebsikdarV (1994) Absence of neuroleptic-induced parkinsonism in psychotic patients receiving adjunctive electroconvulsive therapy. Convuls Ther 10: 53–58Google Scholar
  478. 84.
    Nedopil N (1993) Die medikamentöse Versorgung als Heilbehandlung gemäß §1904 BGB. FamRZ 1: 24–27Google Scholar
  479. 85.
    Neubauer H (1993) Kriterien für die Beurteilung der Einwilligungsfähigkeit bei psychisch Kranken. Psychiat Prax 20: 166–171Google Scholar
  480. 86.
    Newman ME, Gur E, Shapira B, Lerer B (1998) Neurochemical mechanisms of action of ECS: evidence from in vivo studies. J ECT 14: 153–171Google Scholar
  481. 87.
    Nisijima K, Ishiguro T (1999) Electroconvulsive therapy for the treatment of neuroleptic malignant syndrome with psychotic symptoms: a report of five cases. J ECT 15: 158–163Google Scholar
  482. 88.
    Nobler MS, Sackeim H (1993) Augmentation strategies in electroconvulsive therapy: a synthesis. Convuls Ther 9: 331–335PubMedGoogle Scholar
  483. 89.
    Pataki J, Zervas IM, Jandorf L (1992) Catatonia in a university inpatient service (1985–1990). Convuls Ther 8: 163–173PubMedGoogle Scholar
  484. 90.
    Pridmore S, Pollard C (1996) Electroconvulsive therapy in Parkinson’s disease: 30 month follow up. J Neurol Neurosurg Psychiatry 60: 693PubMedGoogle Scholar
  485. 91.
    Richter S (1994) Zur Anwendbarkeit der §§ 1904 BGB, 69d FGG bei Elektrokrampfbehandlungen psychisch Kranker. FamRZ 18: 1204–1205Google Scholar
  486. 92.
    Ries RK, Wilson L, Bokan JA, Chiles JA (1981) ECT in medication resistant schizoaffective disorder. Compr Psychiatry 22: 167–73PubMedGoogle Scholar
  487. 93.
    Rosenquist KJ, Walker SS, Ghaemi SN (2002) Tardive dyskinesia and Ziprasione. Am J Psychiatry 159: 1436PubMedGoogle Scholar
  488. 94.
    Royal College of Psychiatrists (1998) ECT.-1995: Second Report of the Royal College of Psychiatrists,Special Committee on ECT. I. Freeman, Chris II. Dorchetser: Henry Ling Ltd, Dorset Press; reprinted in 1998Google Scholar
  489. 95.
    Royal College of Psychiatrists (1989) Freeman CP, Crammer JL, Deakin JWF, McClelland R, Mann SA, Pippard J (eds) The practical administration of electroconvulsive therapy (ECT). London: GaskellGoogle Scholar
  490. 96.
    Sachdev P, Mason C, Hadzi-Pavlovic D (1997) Case-control study of neuroleptic malignant syndrome. Am J Psychiatry 154: 1156–1158PubMedGoogle Scholar
  491. 97.
    Sackeim HA (1999)The anticonvulsant hypothesis of the mechanisms of action of ECT: current status.] ECT 15: 5–26Google Scholar
  492. 98.
    Sackeim HA, Prudic J, Devanand DP, Kiersky JE, Fitzsimons L, Moody BJ, McElhiney MC, Coleman EA, Settembrino JM (1993) Effects of stimulus intensity and electrode placement on the efficacy and cognitive effects of electroconvulsive therapy. N Engl J Med 328: 839–846PubMedGoogle Scholar
  493. 99.
    Sackeim HA, Prudic J, Devanand DP, Nobler MS, Lisnaby SH, Peyser S, Fitzsimons L, Moody BJ, Clark J (2000) A prospective, randomised, double-blind comparison of bilateral and right unilateral ECT at different stimulus intensities. Arch Gen Psychiatry 57: 425–434PubMedGoogle Scholar
  494. 100.
    Sajatovic M, Meltzer HY (1993) The Effect of Short-Term Electroconvulsive Treatment Plus Neuroleptics in Treatment-Resistant Schizophrenia and Schizoaffective Disorder. Convuls Ther 9: 167–175PubMedGoogle Scholar
  495. 101.
    Sakel M (1935) Neue Behandlungsmethoden der Schizophrenie. Perthes. Wien, LeipzigGoogle Scholar
  496. 102.
    Sauer H, Lauter H (1987) Elektrokrampftherapie. Nervenarzt 58: 201–209Google Scholar
  497. 103.
    Scheftner WA, Shulman RB (1992)Treatment Choice in Neuroleptic Malignant Syndrome. ConvulsTher 8: 267–279Google Scholar
  498. 104.
    Schneeweiß B, Zinkler M (2000) Zur Frage der Genehmigungspflicht von Elektrokrampftherapie im Rahmen einer Betreuung (§1904 BGB): Anmerkungen. Nervenarzt 71: 222–223Google Scholar
  499. 105.
    Schuld A, Kuhn M, Haack M, Kraus T, Hinze-Selch D, Lechner C, PollmacherT (2000) A comparison of the effect of clozapine and olanzapine on the EEG in patients with schizophrenia. Pharmacopsychiatry 33: 109–111Google Scholar
  500. 106.
    Silva RR, Munoz DM, Alpert M, Perlmutter IR, Diaz J (1999) Neuroleptic malignant syndrome in children and adolescents. J Am Acad Child Adolesc Psychiatry 38: 187–194PubMedGoogle Scholar
  501. 107.
    Small JG (1985) Efficacy of Electroconvulsive Therapy in Schizophrenia, Mania, and other Disorders. I. Schizophrenia. ConvulsTher 1: 263–270Google Scholar
  502. 108.
    Smith K, Surphlis WR; Gynther MD, Shimkunas AM (1967) ECT chlorpromazine and chlorpromazine compared in the treatment of schizophrenia. J Nery Ment Disease 144: 284–290Google Scholar
  503. 109.
    Smith S, Lindefors N, Hurd Y, Sharp T (1995) Electroconvulsive shock increases dopamine D1 and D2 receptor mRNA in the nucleus accumbens of the rat. Psychopharmacology (Berl) 120: 333–40Google Scholar
  504. 110.
    Spiess-Kiefer C, Hippius H (1986) Neuroleptisches Syndrom and Maligne Hyperthermie: ein Vergleich. Fortschr Neurol Psychiatr 54: 158–170PubMedGoogle Scholar
  505. 111.
    Strömgren LS (1997) ECT in acute delirium and related clinical states. ConvulsTher 13: 10–17Google Scholar
  506. 112.
    Tarsy D, Baldessarini RJ, Tarazi Fl (2002) Effects of newer antipsychotics on extrapyramidal function. CNS Drugs 16: 23–45PubMedGoogle Scholar
  507. 113.
    Taylor PJ, Fleminger JJ (1980) ECT for schizophrenia. Lancet 1: 1380–1382PubMedGoogle Scholar
  508. 114.
    Tharyan P, Adams CE (2002) Electroconvulsive therapy for schizophrenia (Cochrane Review). Cochrane Database Syst Rev 2: CD000076Google Scholar
  509. 115.
    Trollor JN, Sachdev PS (1999) Electroconvulsive treatment of neuroleptic malignant syndrome: a review and report of cases. Aust N Z J Psychiatry 33: 650–659PubMedGoogle Scholar
  510. 116.
    Tsuang MT, Dempsey GM, Fleming JA (1997) Can ECT prevent premature death and suicide in,schizoaffective’ patients? J Affect Disord 1: 167–171Google Scholar
  511. 117.
    Unterbringungsgesetz Hersausgeber G. Hopf, G. Aigner. Wien 1993 Manzsche Verlags-und Universitätsbuchhandlung. Sonderausgabe 82Google Scholar
  512. 118.
    Weller EB, Weller RA (2000) Treatment options in the management of adolescent depression. J Affect Disord 61 [Suppl 11: 23–28Google Scholar
  513. 119.
    World Health Organization (1979) Schizophrenia. An international Follow up Study. New York, WileyGoogle Scholar
  514. 120.
    Yoshida K, Higuchi H, Kamata M, Yoshimoto M, Shimizu T, HishikawaY (1998) Single and repeated electroconvulsive shocks activate dopaminergic and 5-hydroxytryptaminergic neurotransmission in the frontal cortex of rats. Prog Neuropsychopharmacol Biol Psychiatry 22 (2): 435–444Google Scholar
  515. 121.
    Zis AP, Nomikos GG, Damsma G, Fibiger HC (1991) In vivo neurochemical effects of electroconvulsive shock studied by microdialysis in rat striatum. Psychopharmacology 103: 343–350PubMedGoogle Scholar
  516. 1.
    Abrams R (1997) ElectroconvulsiveTherapy, 3rd edn. Oxford University Press, NewYork, 382Google Scholar
  517. 2.
    Abrams R (2000)….and there’s no proof of lasting brain damage. Nature 403: 826Google Scholar
  518. 3.
    American Psychiatric Association (1999) Treatment guidelines for the treatment of patients with Schizophrenia. Am J Psychiatry 154: 1–63Google Scholar
  519. 4.
    Andrade C, Kurinji S (2002) Continuation and maintenance ECT: a review of recent research. J ECT 18 (3): 149–158Google Scholar
  520. 5.
    Andrade C (2001) Electroconvulsive therapy for Schizophrenia. In: Mandal MK, Nizamie H (eds) Schizophrenia. Oxford University PressGoogle Scholar
  521. 6.
    Asnis F, Gabriel AN (1976)ECT as Maintenance therapy in schizophrenia. Am J Psychiatry 133: 858–859Google Scholar
  522. 7.
    Azorin JM, Spiegel R, Remington G, Vanelle JM, Pere JJ, Giuguere M, Bourdeix I (2001) A double-blind comparative study of clozapine and risperidone in the management of severee chronic schizophrenia. 158: 1305–13Google Scholar
  523. 8.
    Barnes RC, Hussein A, Anderson DN, et al (1997) Nainetenance ECT and cognitive function. Br J Psychiatry 170: 285–7PubMedGoogle Scholar
  524. 9.
    Blake LM, Marks RC, Luchins DJ (1992) Reversible neurologic symtpoms with clozapine and lithium—letter. J Clin Psychopharmacol 12: 297–299PubMedGoogle Scholar
  525. 10.
    Carman JS, Bigelow LB, Wyatt RJ (1981) Lithium combined with neuroleptics in chronic schizophrenic and schizoaffective patients. J Clin Psychiatry 42: 124–128PubMedGoogle Scholar
  526. 11.
    Carpenter WT Jr, Conley RR, Buchanan RW, Breier A, Tamminga CA (1995) Patient response and resource management: Another view of clozapine treatment of schizophrenia. Am J Psychiatry 152: 827–832Google Scholar
  527. 12.
    Centorrino F, Baldessarini RJ, Frankenburg FR, Kando JC, Volpicelli SA, Flood J G (1994) Serum levels of clozapine and norclozapine and its major metabolites: Effects of cotratment with fluoxetine or valporate. Am J Psychiatry 153: 820–822Google Scholar
  528. 13.
    Chanpattana W, Chakrabhand MLS, Kongsakon R, et al (1999) Short-term effect of combined ECT and neuroleptic therapy in treatment resistant schizophrenia. J ECT 15: 129–139Google Scholar
  529. 14.
    Chanpattana W, Kramer BA (2003) Acute and maintenance ECT with flupentixol in refractory schizophrenia: sustained improvements in psychopathology, quality of life, and social outcomes. Schizophrenia Research (in press)Google Scholar
  530. 15.
    Chanpattana W, Somchai Chakrabhand ML, Buppanharun W, Sackeim HA (2000) Effects of Stimulus Intensity on the Efficacy of Bilateral ECT in Schizophrenia: A Preliminary Study. Biol Psychiatry 48: 222–228Google Scholar
  531. 16.
    Chanpattana W, Somchai Chakrabhand ML, Sackheim HA, Kitaroonchai W, Kongsakon R, Techakasem P, Buppanharun W, TuntirungseeY, Kirdcharoen N (1999) Continuation ECT in Treatment-resistant Schizoprenia: a controlled Study. J ECT 15 (3): 178–192Google Scholar
  532. 17.
    Chanpattana W, Somchai Chakrabhand ML (2001) Combined ECT and neuroleptic therapy in treatment-refractory schizophrenia: prediction of outcome. Psychiatry Research 105: 107115Google Scholar
  533. 18.
    Childers R, Therien R (1961) Comparison of the effectiveness of trifluoperazine and chlorpromazine in schizophrenia. Am J Psychiatry 118: 552–554PubMedGoogle Scholar
  534. 19.
    Chong SA, Remington G (2000) Clozapine augmentation: Safety and Efficacy. Schizophr Bull 26: 421–440Google Scholar
  535. 20.
    Christoson, GW, Kirch DG, Wyatt RJ (1991) When symptoms persist: Choosing among alternative treatments for schizophrenia. Schizophrenia Bulletin 17 (2): 217–245Google Scholar
  536. 21.
    Coffey CE, Weiner RD (1990) Electroconvulsive therapy: an update. Hosp Community Psychiatry 41 (5): 515–521PubMedGoogle Scholar
  537. 22.
    Cohen D, Taieb O, Flaument M, Benoit N, Chevret S, Corcis M, Fossati P, Jeammet P, Alliaire J F, Basquin M (2000) Absence of Cognitive Impairment at Long-Term Follow-Up in Adolescents Treated With ECT for Severe Mood Disorder. Am J Psychiatry 157 (3): 460–462PubMedGoogle Scholar
  538. 23.
    Conley RR,Tamminga CA, Bartko JJ, Richardson C, Peszke M, Lingle J, et al (1999)Treatmentresistant schizophrenic patients respond to clozapine after olanzapine non-response. Biol Psychiatry 46: 73–77Google Scholar
  539. 24.
    Datto CJ, Levy S, Miller DS, et al (2001) Impact of maintenance ECT on concentration and memory. J ECT 17: 170–174Google Scholar
  540. 25.
    Datto CJ (2000) Side effects of electroconvulsive therapy. Depression and Anxiety 12: 130134Google Scholar
  541. 26.
    Davis JM, Casper R (1977) Antipsychotic drugs: Clinical pharmacology and therapeutic use. Drugs 14: 260–282Google Scholar
  542. 27.
    Devanand DP, Dwork At Hutchinson ER, et al (1994) Does ECT alter brain structure? Am J Psychiatry 151: 957–70PubMedGoogle Scholar
  543. 28.
    Dodwel I D, Goldberg D (1989) A study of factors associated with response to electroconvulsive therapy in patients with schizophrenic symptoms. Br J Psychiatry 154: 635–639Google Scholar
  544. 29.
    Eranti SV, McLoughlin DM (2003) ElectroconvulsiveTherapy — state of the art. Br J Psychiatry 182: 8–9PubMedGoogle Scholar
  545. 30.
    Essock SM, Hargreaves WA, Dohm FA, Goethe J, Carver L, Hipshman L (1996) Clozapine Eligibility among state hospital patients. Schizophrenia Bulletin 22: 15–25PubMedGoogle Scholar
  546. 31.
    Faisal I, Lindenmeyer JP, Tatintor Z, Cancro R (1997) Clozapine-benzodiazepine interactions. J Clin Psychiatry 58 (12): 547–548PubMedGoogle Scholar
  547. 32.
    Fink M, Abrams R, Bailine S, et al (1996) Ambulatory electroconvulsive therapy: report of a task force of the Association for Convulsive Therapy. Convuls Ther 12: 42–55PubMedGoogle Scholar
  548. 33.
    Fink M, Sackeim HA (1996) Convulsive Therapy in Schizophrenia? Schiz Bull 22 (1): 27–39Google Scholar
  549. 34.
    Fink M (1990) Clozapine and electroconvulsive therapy. Arch Gen Psychiatry 47: 290–291PubMedGoogle Scholar
  550. 35.
    Fink M (1991) Impact of the antipsychiatry movement on the revival of electroconvulsive therapy in the United States. Psychiatr Clin North Am 14 (4): 793–801PubMedGoogle Scholar
  551. 36.
    Fleischhacker WW (1999) Clozapine: a comparison with other novel antipsychotics. J Clin Psychiatry 60 [Suppl 12]: 30–34PubMedGoogle Scholar
  552. 37.
    Friedel RO (1986)The combined use of neuroleptics and ECT in drug resistant schizophrenic patients. Psychopharmacol Bull 22: 928–930Google Scholar
  553. 38.
    Geddes J, Freemantle N, Harrison P, Bebbington P (2000) Atypical antipsychotics in the treatment of schizophrenia: systematic overview and meta-regression analysis. BMJ (2); 321 (7273): 1371–1376Google Scholar
  554. 39.
    Gelenberg AL (1989) Clozapine induced agranulocytosis and seiures. Biol Ther Psychiatr 12: P2–3Google Scholar
  555. 40.
    Gujavarty K, Greenberg L, Fink M (1987) Electroconvulsive therapy and neuroleptic medication in therapy-resistant positive-symptom psychosis. Convuls Ther 3: 185–95PubMedGoogle Scholar
  556. 41.
    Guy W (1976) ECDEU Assessment manual for psychopharmacology. US Dept of Health and Human Services publication. ADM 76 (338): 524–535Google Scholar
  557. 42.
    Hay AG, Scott AIF (1994) Electroconvulsive therapy and brain damage. Br J Psychiatry 165: 120–121PubMedGoogle Scholar
  558. 43.
    Hegarty JD, Badessarini RJ, Tohen M, Waternaux C, Oepen G (1994) One hundred years of schizophrenia: a meta-analysis of the outcome literature. Am J Psychiatry 151: 1409–1416PubMedGoogle Scholar
  559. 44.
    Hoffler J, Trenckmann U, Graf von der Schulenburg JM (2000) Health economics and evaluation of schizophrenic psychosis in Germany. Fortschr Neurol Psychiatr 68 [Suppl 11: 7–12Google Scholar
  560. 45.
    Jackson CW, Markowitz JS, Brewerton TD (1995) Delirium associated with clozapine and benzodieazepine combinations. Ann Clin Psychiatry 7 (3): 139–141PubMedGoogle Scholar
  561. 46.
    Kales HC, Dequardo JR, Tandon R (1999) Combined electroconvulsive therapy and clozapine in treatment resistant schizophrenia. Prog. Neuro-Psychopharmacol Biol Psychiat 23: 547–556Google Scholar
  562. 47.
    Kane J, Honigfeld G, Singer J, Meltzer H (1988) Clozapine for the treatment-resistant schizophrenic: A double-blind comparison with chlorpromazine. Arch Gen Psychiatry 45: 789–796Google Scholar
  563. 48.
    Kane JM, Honigfeld G, Singer J, Meltzer HY and the Clozaril Collaborative Study Group (1988) Clozapine for the treatemt-resistant schizophrenic: A double-blind comparison with chlorpromazine. Archives of General Psychiatry 45: 789–796Google Scholar
  564. 49.
    Kane JM, Marder SR (1993) Psychopharmacologic treatment of Schizophrenia. Schiz Bull 19: 287–302Google Scholar
  565. 50.
    Kane JM (1992) Clinical efficacy of clozapine in treamtent refractory schizophrenia: an overview. Br J Psychiatry 160 [Suppl 17]: 41–45Google Scholar
  566. 51.
    Karliner W, Wertheim HK (1965) Maintenance convulsive treatments. Am J Psychiatry 212: 1113–1115Google Scholar
  567. 52.
    Keks NA, Altson K, Hope J, Krapivensky N, Culhane C, Tanaghow A, Doherty P, Bootle A (1999) Use of antipsychotics and adjunctive medications by an inner urban community psychiatric service. Austr NZ J Psychiatry 33 (6): 896–901Google Scholar
  568. 53.
    Kellner CH, Burns CM, Bernstein HJ, et al (1991) Electorde placement in maintenance electroconvulsive therapy. Convuls Ther 7: 61–62PubMedGoogle Scholar
  569. 54.
    Klein HE, Rüther E (1983) Klinisch bedeutsame Wechselwirkungen der Psychopharmaka. In: Langer G, Heimann H (Hrsg) Psychopharmaka. Grundlagen undTherapie. Springer, Wien New York, 617–635Google Scholar
  570. 55.
    Konig P, Glatter-Gotz U (1990) Combined electroconvulsive and neuroleptic therapy in schizophrenia refractory to neuroleptics. Schizophrenia Res 3: 351–354Google Scholar
  571. 56.
    Krueger RB, Sackeim HA (1995) Electroconvulsive therapy and schizophrenia. In: Hirsch S, Weinberger D (eds) Schizophrenia. Blackwell, Oxford, England, pp 503–545Google Scholar
  572. 57.
    Krueger, RB, Sackheim HA (1995) Electroconvulsive therapy of schizophrenia. In: Hirsch S, Weinberger D (eds) Schizophrenia. Oxford University Press, Oxford, pp 503–545Google Scholar
  573. 58.
    Kupchik M, Spivak B, Mester R, Reznik I, Gonen N, Weizman A, Kotler M (2000) Combined Electroconvulsive-Clozapine Therapy. Clinical Neuropharmacology 23 (1): 14–16 )PubMedGoogle Scholar
  574. 59.
    Lewis AB (1982) ECT in drug-refractory schizophrenics. Hill J Clin Psychiatry 4: 141–54Google Scholar
  575. 60.
    Marder SR, Ames D, Wirshing WC, Van Putten T (1993) Schizoprenia. Psychiatr Clin N Am 16: 567–87Google Scholar
  576. 61.
    May PR, Tuma AH, Dixon WJ, Yale C, Thiele DA, Kraude WH (1981) Schizophrenia: A fol low-up study of the results of five forms of treatment. Archives of General Psychiatry 38: 776–784Google Scholar
  577. 62.
    Mc Glashan TH (1988) A selective review of recent North American long term follow up studies of schizophrania. Schizophrenia bulletin 14: 515–542Google Scholar
  578. 63.
    McCall WV, Reboussin DM, Weiner RD, Sackeim HA (2000)Titrated moderately supratreshold vs fixed high-dose right unilateral electroconvusliver therapy: acute antidepressant and cognitive effects. Arch Gen Psychiatry 57(5): 438–44Google Scholar
  579. 64.
    Meduna L (1939) Die Konvulsionstherapie der Schizophrenie: Rückblick and Ausblick. Psychiatrisch-neurologische Wochenschrift 41: 165–169Google Scholar
  580. 65.
    Meduna L (1985) Autobiography of LO. J. Meduna Convuls Ther 1: 43–57, 121–135Google Scholar
  581. 66.
    Meltzer HY, Bastani B, Kwon KY, Ramierz LF, Burnett S, Shape J (1989) A prospective study of clozapine in treatment-resistant schizophrenia patients. Psychopharmacology 99: 568–72Google Scholar
  582. 67.
    Meltzer HY (1992) Treatment of the Neuroleptic-Nonresponsive Schizophrenic Patient. Schiz Bull 18 (3): 515–42Google Scholar
  583. 68.
    Miller AL, Chiles JA, Chiles JK, Crimson ML, Rush JA, Shon SP (1999) The Texas Medication Algorithm Project ( TMAP) schizophrenia algorithms. J Clin Psychiatry 60: 649–657Google Scholar
  584. 69.
    Milstein V, Small JG, Miller JG, et al (1990) Mechanisms of action of ECT: schizophrenia and schizoaffective disorder. Biol Psychiatry 27: 1282–1292PubMedGoogle Scholar
  585. 70.
    Möller HJ (1996)Therapie mit Neuroleptika. In: Möller HJ, Schmauß M (Hrsg) Arzneimitteltherapie in der Psychiatrie. Wiss. Verl.-Ges., Stuttgart, 147–224Google Scholar
  586. 71.
    Moore NP (1943) The maintenance treatment of chronic psychosis by electrically induced convulsions. Journal of Mental Sciences 89: 257–259Google Scholar
  587. 72.
    Morera AL, Barriero P, Cano-Munoz JL (1999) Risperidone and clozapine combination for the treatment of refractory schizophrenia. Acta Psychiatr Scand 99 (4): 305–306PubMedGoogle Scholar
  588. 73.
    Müller U, Klimke A, Jänner M, Gaebel W (1998) Die Elektrokrampftherapie in psychiatrischen Kliniken der Bundesrepublik Deutschland 1995. Nervenarzt 69: 15–26PubMedGoogle Scholar
  589. 74.
    Naber D, Holzbach R, Perro C, Hippius H (1992) Clinical management of clozapine patients in relation to efficacy and side effects. Br J Psychiatry 160 [Suppl 171: 54–59Google Scholar
  590. 75.
    Overall JE, Gorham DE (1961) The brief psychiatric rating scale. Psycho) reports 10: 799–812Google Scholar
  591. 76.
    Peusekens J (1998) Good medical practice in antipsychotic pharmacotherapy. Int Clin Psychopharmacol 13 [Suppl 3]: 35–41Google Scholar
  592. 77.
    Philpot M, Treloar A, Gormley N, Gustafson L (2002) Barriers to the use of electroconvulsive therapy in the elderly: A European Survey. Eur Psychiatry 17: 41–5Google Scholar
  593. 78.
    Rabheru K, Persad E (1997) A review of continuation and maintenance electroconvulsive therapy. Can J Psychiatry 42 (5): 476–84PubMedGoogle Scholar
  594. 79.
    Rahman A (1968) A review of treatment of 176 schizophrenic patients in the mental hospital Pabna Br J Psychiatry 114: 775–7Google Scholar
  595. 80.
    Royal College of Psychiatrists (1995) The ECT Handbook. The Second Report of the Royal College of Psychiatrist’s Special Committee on ECT (Council Report CR 39 ). London: Royal College of PsychiatristsGoogle Scholar
  596. 81.
    Sackeim HA, Prudic J, Devanand DP, Kiersky JE, Fitzsimons L, Moody BJ, et al (1993) Effects of stimulus intensity and electrode placement on the efficacy and cognitive effects of electroconvulsive therapy. N Engl J Med 328: 839–847PubMedGoogle Scholar
  597. 82.
    Sackeim HA, Prudic J, Devanand DP, Nobler MS, Lisanby SH, Peyser S, Fitzsimons L, Moody BJ, ClarkJ (2000) A prospective, randomized, double-blind comparison of bilateral and right unilateral ECT at different stimulus intensities. Arch Gen Psychiatr 57 (5): 425–34Google Scholar
  598. 83.
    Sackeim HA (1994) Central issues regarding the mechanisms of action of electroconvulsive therapy: directions for future research. Psychopharmacol Bull 30: 281–308PubMedGoogle Scholar
  599. 84.
    Sajatovic M, Meltzer HY (1993) The effect of short-term electroconvulsive treatment plus neuroleptics in treatment-resistant schizophrenia and schizoaffective disorder. ConvulsTher 9: 167–75Google Scholar
  600. 85.
    Salzman C (1980) The use of ECT in the treatment of schizophrenia. Am J Psychiatry 137: 1032–41PubMedGoogle Scholar
  601. 86.
    ScottA (1995) Continuation ECT (Maintenance ECT). In: Freeman CP (ed)The ECT Handbook. The Second Report of the Royal College of Psychiatrists’ Special Committee on ECT. London: Royal College of Psychiatrists, 72Google Scholar
  602. 87.
    Scott Al, Weeks DJ, McDonald CF (1991) Continuation electroconvulsive therapy: preliminary guidelines and an illustrative case report. Br J Psychiatry 159: 867–70Google Scholar
  603. 88.
    Shiloh R, Zemishlany Z, Aizenberg D, Radwan M, Schwartz B, Dorfman-Etrog P, et al (1997) Sulpiride augmentation in people with schizophrenia partially responsive to clozapine: A double-blind, placebo-controlled study. Br J Psychiatry 171: 569–573Google Scholar
  604. 89.
    Smith K, Surphlis WRP, Gynther MD, Shimkunas A (1967) ECT-chlorpromazine and chlorpormazine compared in the treatment of schizophrenia. J Nery Ment Dis 144: 284–290Google Scholar
  605. 90.
    Smith TE, Docherty JP (1998) Standards of care and clinical algorithms for treating schizophrenia. Psychiatr Clin North Am 21: 203–220PubMedGoogle Scholar
  606. 91.
    Stahl SM (1999) Antipsychotic polypharmacy, Part 1: Therapeutic option or dirty little secret? J Clin Psychiatry 60 (7): 425–6PubMedGoogle Scholar
  607. 92.
    Stahl SM (1999) Antipsychotic polypharmacy, Part 2: tips on use and misuse. J Clin Psychiatry 60 (8): 506–7PubMedGoogle Scholar
  608. 93.
    Stevenson GH, Geoghegan JJ (1951) Prophylactic Electroshock. Am J Psychiatry 107: 743748Google Scholar
  609. 94.
    Tharyan P, Adams CE (2002) Electroconvulsive therapy for schizophrenia. Chochrane Database Syst Rev 2: CD000076Google Scholar
  610. 95.
    The Practice of ECT (1990) Recommendations for Practice, Training, and Privileging. Task Force Report on ECT. American Psychiatric Press, Washington, DCGoogle Scholar
  611. 96.
    Thompson JW, Weiner RD, Myers CP (1994) Use of ECT in the United States in 1975, 1980, and 1986. Am J Psychiatr 151: 1657–1661PubMedGoogle Scholar
  612. 97.
    Treatment of Schizophrenia (1999) The expert consensus guideline series. JClin Psych iatr60 [Suppl 1 1]: 3–80.Google Scholar
  613. 1.
    Aarsland D, Larsen P, Waage O (1997) Maintenance electroconvulsive therapy in Parkinson’s disease. ConvulsTher 13: 274–277Google Scholar
  614. 2.
    Abrams R (1990) ECT as prophylactic treatment for bipolar disorder. Am J Psychiatry 147: 373–374PubMedGoogle Scholar
  615. 3.
    Abrams R (1997) Electroconvulsive therapy. 3rd edn. Oxford University Press, New York, 191Google Scholar
  616. 4.
    Alexopoulos Gs, Young RC, Abrams RC (1989) ECT in the high-risk geriatric patient. Convuls Ther 8: 75–87Google Scholar
  617. 5.
    American Psychiatric Association Task Force on Electroconvulsive Therapy (1990)The practice of electroconvulsive therapy: recommendations for treatment, training, and privileging. APA Press, Washington DCGoogle Scholar
  618. 6.
    Andrade C, Kurinji S (2002) Continuation and maintenance ECT: a review of recent research. J ECT 18: 149–158Google Scholar
  619. 7.
    Angst J, Angst K, Baruffol I, Meinherz-Surbeck R (1992) ECT-imduced and drug-induced hypomania. ConvulsTher 8: 179–185Google Scholar
  620. 8.
    Aronson TA, Shukla S, HoffA (1987) Continuation therapy of ECT for delusional depression: a naturalistic study of prophylaptic treatments and relapse. ConvulsTher 3: 251–259Google Scholar
  621. 9.
    Association for Convulsive Therapy (1996). Ambulatory electroconvulsive therapy: report of a task force of the Association for Convulsive Therapy. ConvulsTher 12: 41–55Google Scholar
  622. 10.
    Barnes RC, Hussein A, Anderson DN, Powell D (1997) Maintenance electroconvulsive therapy and cognitive function. Br J Psychiatry 170: 285–287PubMedGoogle Scholar
  623. 11.
    Beale MD, Bernstein HJ, Kellner CH (1996) Maintenance electroconvulsive therapy for geriatric depression: a one-year follow-up. Clin Gerontologist 16: 86–90Google Scholar
  624. 12.
    Benbow SM (1991) ECT in late life. Int J Geriatric Psychiatry 6: 401–406Google Scholar
  625. 13.
    Bonds C, Frye MA, Coudreaut MF (1998) Cost reduction with maintenance ECT in refractory bipolar disorder. J ECT 14: 36–41Google Scholar
  626. 14.
    Burke WJ, Rubin EH, Zorumski CF, Wetzel RD (1987) The safety of ECT in geriatric psychiatry. J Am Geriatr Soc 35: 516–521PubMedGoogle Scholar
  627. 15.
    Casey DA, Davis MH (1994) Obsessive-compulsive disorder responsive to electroconvulsive therapy in an elderly woman. South Med J 87: 862–864PubMedGoogle Scholar
  628. 16.
    Cattan RA, Barry PP, Mead G, Reefe WE, Gay A, Silverman M (1990) Electroconvulsive therapy in octogenarians. J Am Geriatr Soc 38: 753–758PubMedGoogle Scholar
  629. 17.
    Chanpattana W, Chakrabhand MLS, Sackeim HA, Kitaroonchai W, Kongsakon R, Techakasem P, Buppanharun W, TuntirungseeY, Kirdcharoen N (1999) Continuation ECT in treatment-resistant schizophrenia: a controlled study. J ECT 15: 129–139Google Scholar
  630. 18.
    Clarke TB, Cofey CE, Hoffman GW, Weiner RD (1989) Continuation therapy for depression using outpatient electroconvulsive therapy. ConvulsTher 5: 330–337Google Scholar
  631. 19.
    Coppen A, Abouh-Saleh MT, Milln P (1981) Lithium continuation therapy following electroconvulsive therapy. Br J Psychiatry 139: 284–287PubMedGoogle Scholar
  632. 20.
    Datto CJ, Levy S, Miller DS, Katz IR (2001) Impact of maintenance ECT on concentration and memory. J ECT 17: 170–174Google Scholar
  633. 21.
    Decina P, Guthrie EB, Sackeim HA, Kahn D, Malitz S (1987) Continuation ECT in the management of relapses of major affective episodes. Acta Psychiatr Scand 75: 559–562PubMedGoogle Scholar
  634. 22.
    Douyon R, Serby M, Klutchko B, Rotrosen J (1989) ECT and Parkinson’s disease revisted: a „natural istic“ study. Am J Psychiatry 146: 1451–1455PubMedGoogle Scholar
  635. 23.
    Dubin WR, Jaffe R, Roemer R, Siegel L, Shoyer B,Venditti ML (1992)The efficacy and safety of maintenance ECT in geriatric patients. J Am Geriatr 40: 706–709Google Scholar
  636. 24.
    Fall PA, Granerus AK (1999) Maintenance ECT in Parkinson’s disease. J Neural Transm 106: 737–741PubMedGoogle Scholar
  637. 25.
    Fink M (1987) Maintenance ECT and affective disorder. ConvulsTher 3: 249–250Google Scholar
  638. 26.
    Fink M (1991) ECT in long-term follow-up of BPD. Biol Psychiatry 30: 1172PubMedGoogle Scholar
  639. 27.
    Fox HA (2001) Extended continuation and maintenance ECT for long-lasting episodes of major depression. J ECT 17: 60–64Google Scholar
  640. 28.
    Francis A, Fochtmann L (1993) Sustained down regulation of cortical beta-adrenergic receptor density with maintenance ECS. ConvulsTher 9: 185–1991Google Scholar
  641. 29.
    Friedman J, Gordon N (1992) Electroconvulsive Therapy in Parkinson’s Disease: A Report on Five Cases. ConvulsTher 8: 204–210Google Scholar
  642. 30.
    Husain MM, Meyer DE, Muttakin MH, Weiner MF (1993) Maintenance ECT for treatment of recurrent mania. Am J Psychiatry 150: 985PubMedGoogle Scholar
  643. 31.
    Gagne GG, Furman MJ, Carpenter LL, Price LH (2000) Efficacy of continuation ECT and antidepressant drugs compared to long-term antidepressants alone in depressed patients. Am J Psychiatry 157: 1960–1965PubMedGoogle Scholar
  644. 32.
    Gerbaldo H, Müller-Siecheneder F (1996) Significance of primary negative symptoms in schizophrenic and other psychiatric patients. Fortschr Neurol Psychiatr 64: 221–227PubMedGoogle Scholar
  645. 33.
    Grunze H, Erfurth A, Schäfer M, Amann B, Meyendorf R (1999) Electroconvulsive therapy in the treatment of severe mania. Case report and a state-of-art review. Nervenarzt 70: 662–667Google Scholar
  646. 34.
    Gupta S, Austin R, Devanand DP (1998) Lithium and maintenance electroconvulsive therapy. J ECT 14 (4): 241–244Google Scholar
  647. 35.
    Imlah NW, Ryan E, Harrington JA (1965) The influence of antidepressant drugs on the response to electroconvulsive therapy and on subsequent relapse rates. Neuropsychopharmacology 4: 438–442Google Scholar
  648. 36.
    Jaffe R, Dubin W, Shoyer B, Roemer R, Sharon D, Lipschütz L (1990) Outpatient electroconvulsive therapy: efficacy and safety. ConvulsTher 6: 231–238Google Scholar
  649. 37.
    Jaffe RL, Rives W, Dubin WR, Roemer RA, Siegel L (1991) Problems in maintenance ECT in bipolar disorder: replacement by lithium and anticonvulsants. ConvulsTher 7: 288–294Google Scholar
  650. 38.
    Karliner W, Wehrheim HK (1965) Maintenance convulsive treatments. Am J Psychiatry 121: 1113–1115PubMedGoogle Scholar
  651. 39.
    Kellner CH, Burns CM, Bernstein HJ, Monroe RR (1991) Electrode placement in maintenance electroconvulsive therapy. ConvulsTher 7: 61–62Google Scholar
  652. 40.
    Kellner CH, Pritchett JT, Beale MD, Coffey CE (1997) Handbook of ECT. American Psychiatric Press Inc, Washington DCGoogle Scholar
  653. 41.
    Kramer BA (1987) Maintenance ECT: a survey of practice (1986). ConvulsTher 3: 260–268Google Scholar
  654. 42.
    Kramer BA (1999) A naturalistic review of maintenance ECT at a university setting. J ECT 15 (4): 262–269Google Scholar
  655. 43.
    Lippmann SB, Tao CA (1993) Electroconvulsive therapy and lithium: safe and effective treatment. ConvulsTher 9: 54–57Google Scholar
  656. 44.
    Loo H, Galinowski A, de Carvalho W, Bourdel MC, Poirier MF (1991) Use of maintenance ECT for elderly depressed patients. Am J Psychiatry 148: 810PubMedGoogle Scholar
  657. 45.
    Matzen TA, Martin RL, WattTJ, Reilly DK (1988) The use of maintenance electroconvulsive therapy for relapsing depression. Jefferson J Psychiatry 6: 52–58Google Scholar
  658. 46.
    Moore NP (1943) The maintenance treatment of chronic psychotics by electrically induced convulsions. J Mental Sci 89: 257–269Google Scholar
  659. 47.
    Monroe RR Jr (1991) Maintenance electroconvulsive therapy. Psychiatr Clin North Am 14 (4): 947–960PubMedGoogle Scholar
  660. 48.
    Perry P, Tsuang MT (1979) Treatment of unipolar depression following electroconvulsive therapy. J Affect Disord 1: 123–129PubMedGoogle Scholar
  661. 49.
    Petrides G, Dhossche D, Fink M, Francis A (1994) Continuation ECT: relapse prevention in affective disorders. ConvulsTher 10: 189–194Google Scholar
  662. 50.
    Pridmore S, Pollard C (1996) Electroconvulsive therapy in parkinson’s disease: 30 month follow-up. J Neurol Neurosurg Psychiatry 60: 693PubMedGoogle Scholar
  663. 51.
    Rabheru K, Persad E (1997) A review of continuation and maintenance electroconvulsive therapy. Can J Psychiatry 42 (5): 476–484PubMedGoogle Scholar
  664. 52.
    Rasmussen KG, Zorumski CF, Jarvis MR (1993) Electroconvulsive Therapy in Patients with Cerebral Palsy. ConvulsTher 9: 205–208Google Scholar
  665. 53.
    Sackeim HA (1994) Continuation therapy following ECT: directions for future research. Psychopharmacol Bull 30: 501–521PubMedGoogle Scholar
  666. 54.
    Schwarz T, Loewenstein J, Isenberg KE (1995) Maintenance ECT: indications and outcome. Convuls Ther 11 (1): 14–23PubMedGoogle Scholar
  667. 55.
    ScottA (1995) Continuation ECT (maintenance ECT). In: Freeman CP (ed)The ECT Handbook. The Second Report of the Royal College of Psychiatrists’ Special Commitee on ECT. Royal College of Psychiatrists, London, 72Google Scholar
  668. 56.
    Small JG, Milstein V, Small IF (1991) Electroconvulsive therapy for mania. Psychiatr Clin North Am 14: 887–903PubMedGoogle Scholar
  669. 57.
    Srinivasan TN, Suresh TR, Jayaram V (1995) Issues in the use of maintenance electroconvulsive therapy. Indian J Psychiatry 37: 139–142PubMedGoogle Scholar
  670. 58.
    Steffens DC, Krystal AD, Sibert TE, Moore SD, Weiner RD (1995) Cost effectiveness of maintenance ECT. ConvulsTher 11: 283–284Google Scholar
  671. 59.
    Stevens J, Cheung P, LambertT (2001) Maintenance electroconvulsive therapy in schizophrenia. Aust NZ J Psychiatry 35: 132–133Google Scholar
  672. 60.
    Stevenson GH, Geoghegan JJ (1951) Prophylactic electroshock: a 5-year study. Am J Psychiatry 107: 743–748PubMedGoogle Scholar
  673. 61.
    StewartJT (2000) Lithium and maintenance ECT. J ECT 16 (3): 300–301Google Scholar
  674. 62.
    Swoboda E, Conca A, König P, Waanders R, Hansen M (2001) Maintenance electroconvulsive therapy in affective and schizoaffective disorder. Neuropsychobiology 43: 23–28PubMedGoogle Scholar
  675. 63.
    Thienhaus OJ, Margletta S, Bennett JA (1990) A study of the clinical efficacy of maintenance ECT. J Clin Psychiatry 51: 141–144PubMedGoogle Scholar
  676. 64.
    Thornton JE, Mulsant BH, Dealy R, Reynolds CF (1990) A retrospective study of maintenance electroconvulsive therapy in a university-based psychiatric practice. Convuls Ther 6: 121–129PubMedGoogle Scholar
  677. 65.
    Thuppal M, Fink M (1999) Electroconvulsive therapy and mental retardation. J ECT 15: 140–149 Elektrokonvulsionstherapie als Erhaltungstherapie und Rezidivprophylaxe 461Google Scholar
  678. 66.
    Vanelle JM, Loo H, Galinowski A, de Carvalho W, Bourdel MC, Brochier P, Bouvet 0, Borchier T, Olie J-P (1994) Maintenance ECT in intractable manic-depressive disorders. Convuls Ther 10: 195–205PubMedGoogle Scholar
  679. 67.
    van Gorp WG, Altshuler L, Theberge DC, Wilkins J, Dixon W (1998) Cognitive impairment in euthymic bipolar patients with and without prior alcohol dependence. Arch Gen Psychiatry 1998; 55: 41–46Google Scholar
  680. 68.
    Wohlfahrt A (1996) Electroconvulsive therapy in compulsive syndromes. A case report. Nervenarzt 67: 397–399PubMedGoogle Scholar
  681. 69.
    Wolff GE (1957) Results of 4 years active therapy for chronic mental patients and the value of an individual maintenance dose of ECT. Am J Psychiatry 114: 453–458PubMedGoogle Scholar
  682. 70.
    Young R, Alexopoulos G, Shamoian A (1985) Dissociation of motor response from mood and cognition in a parkinsonian patient treated with ECT. Biol Psychiatry 20: 566–569PubMedGoogle Scholar
  683. 71.
    Zervas I, Fink M (1991) ECT for refractory Parkinson’s disease. Convuls Ther 7: 222–22PubMedGoogle Scholar

Copyright information

© Springer-Verlag Wien 2004

Authors and Affiliations

  • Baghai
    • 1
  • Rupprecht
    • 1
  • Möller
    • 1
  • Adli
    • 2
  • Bauer
    • 2
  • Grunze
    • 1
  • Scharfetter
    • 3
  • Schäfer
    • 2
  • Conca
    • 4
  • Riedel
    • 1
  • Strassnig
    • 1
  • Möller
    • 1
  • Müller
    • 1
  • Müller-Siecheneder
    • 1
  • Praschak-Rieder
    • 3
  • Willeit
    • 3
  1. 1.MünchenDeutschland
  2. 2.BerlinDeutschland
  3. 3.WienÖsterreich
  4. 4.RankweilÖsterreich

Personalised recommendations